Introduction {#age12857-sec-0001}
============

The horse (*Equus caballus*, ECA) occupies a special place amongst farm animals. Since domestication about 5500 years ago (Outram *et al*. [2009](#age12857-bib-0197){ref-type="ref"}; Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}; Gaunitz *et al*. [2018](#age12857-bib-0080){ref-type="ref"}), horses have served humans in agriculture, warfare and transportation, and as valued companions. In modern times, they continue to interact with humans in many different ways and are an important part of the leisure industry. Humans have selectively bred horses for performance traits (speed, endurance, strength, gait), appearance (size, color, conformation) and temperament, resulting in 400--500 different breeds (Hendricks [2007](#age12857-bib-0095){ref-type="ref"}; Petersen *et al*. [2013a](#age12857-bib-0205){ref-type="ref"}). The derivation of breeds from selective breeding and the inclusion of only individuals with breed‐defining characteristics have resulted in genomic features that vary among populations (Petersen *et al*. [2013b](#age12857-bib-0206){ref-type="ref"}). Furthermore, over 130 equine hereditary traits (e.g. muscle disorders, allergies, asthma) can serve as valuable models for the study of similar human conditions (Wade *et al*. [2009](#age12857-bib-0282){ref-type="ref"}; OMIA: <https://omia.org/home/>). Interest in economic, biomedical, evolutionary and basic science aspects of the horse combined with intense passion for advancing knowledge on equids have promoted organized studies of the horse genome, initiated at the First International Equine Gene Mapping Workshop in 1995 (reviewed by Chowdhary & Bailey [2003](#age12857-bib-0038){ref-type="ref"}; Finno & Bannasch [2014](#age12857-bib-0068){ref-type="ref"}). Whereas multiple important achievements mark the 25 years of horse genomics (reviewed by (Chowdhary & Bailey [2003](#age12857-bib-0038){ref-type="ref"}; Chowdhary & Raudsepp [2006](#age12857-bib-0039){ref-type="ref"}; Chowdhary *et al*. [2008](#age12857-bib-0041){ref-type="ref"}; Chowdhary & Raudsepp [2008](#age12857-bib-0040){ref-type="ref"}; Finno *et al*. [2009](#age12857-bib-0069){ref-type="ref"}; Brosnahan *et al*. [2010](#age12857-bib-0033){ref-type="ref"}; Bailey & Brooks [2013](#age12857-bib-0008){ref-type="ref"}; Chowdhary [2013](#age12857-bib-0037){ref-type="ref"}; Finno & Bannasch [2014](#age12857-bib-0068){ref-type="ref"}; Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}), without doubt the most important milestone was the generation of the reference genome assembly (Wade *et al*. [2009](#age12857-bib-0282){ref-type="ref"}), made possible through collaborative efforts of the research community. The completion of a reference genome has shaped horse genome studies during the past 10 years and, together with the ongoing revolution in genomics technologies, particularly next‐generation sequencing (reviewed by van Dijk *et al*. [2014](#age12857-bib-0056){ref-type="ref"}, has taken equine genomics to a new level.

This review will focus on these technology‐driven achievements in the post‐genome era of horse genomics: the development of new genomics tools and resources, the improvement of the reference sequence and functional annotation of the horse genome. We will discuss how the cutting‐edge genomics technologies have improved understanding of the evolutionary history of the horse, the genetic makeup of individual horse breeds, and the study of Mendelian and complex traits.

The horse genome {#age12857-sec-0002}
================

EquCab2.0 {#age12857-sec-0003}
---------

In 2019, we celebrate the tenth anniversary of the publication of the genome sequence of the Thoroughbred mare, *Twilight* (Wade *et al*. [2009](#age12857-bib-0282){ref-type="ref"}). The sequence of *Twilight* represented the first equine and Perissodactyl genome and established a reference sequence for the domestic horse (Wade *et al*. [2009](#age12857-bib-0282){ref-type="ref"}). Sequencing was performed using the Sanger method with an average of 6.8‐fold genomic coverage. The contiguity of the assembly was increased by the inclusion of end sequences of approximately 315 000 BAC clones from the CHORI‐241 BAC library, which represents sequences from *Twilight*\'s half‐brother *Bravo* (<https://bacpacresources.org/>; Leeb *et al*. [2006](#age12857-bib-0132){ref-type="ref"}). Radiation hybrid and cytogenetic maps (Raudsepp *et al*. [2008](#age12857-bib-0217){ref-type="ref"}) assisted with chromosomal anchoring and orienting the scaffolds. The result was a high‐quality, 2.5 Gb draft assembly, denoted as EquCab2.0, which incorporated the 31 horse autosomes, the X chromosome and the mitochondrial genome. Sequence annotation by the ENSEMBL pipeline predicted 20 322 protein‐coding genes, comparable with human, mouse and other mammals. An important part of the horse genome project was the identification of over a million SNPs, which directed the development of genomic tools for mapping in the horse. The SNPs were generated from the diploid genome of *Twilight* and by partial sequencing of seven additional horses of diverse breeds. The reference assembly and the SNP map marked a turning point in horse genomics by providing resources for driving subsequent molecular, clinical and evolutionary studies in the horse (reviewed by Wade [2013](#age12857-bib-0281){ref-type="ref"}; Finno & Bannasch [2014](#age12857-bib-0068){ref-type="ref"}; Ghosh *et al*. [2018](#age12857-bib-0085){ref-type="ref"}).

EquCab3.0 {#age12857-sec-0004}
---------

Despite its high quality, EquCab2.0 is a draft assembly and, as a product of the available technology of the time, has limitations (Kalbfleisch *et al*. [2018](#age12857-bib-0116){ref-type="ref"}). The assembly contains numerous gaps, mainly in structurally complex genomic regions, which include segmental duplications and CNV sites (Doan *et al*. [2012](#age12857-bib-0058){ref-type="ref"}; Ghosh *et al*. [2014](#age12857-bib-0083){ref-type="ref"}). Approximately 0.2 Gb of sequence reads in EquCab2.0, mainly highly repetitive regions, remain unassembled and unassigned to chromosomes (Wade *et al*. [2009](#age12857-bib-0282){ref-type="ref"}; Wade [2013](#age12857-bib-0281){ref-type="ref"}). Furthermore, recent re‐sequencing of the whole genome (Rebolledo‐Mendez *et al*. [2015](#age12857-bib-0220){ref-type="ref"}) of selected complex regions such as the MHC (Viluma *et al*. [2017](#age12857-bib-0280){ref-type="ref"}) and part of the PAR (Rafati *et al*. [2016](#age12857-bib-0215){ref-type="ref"}), together with transcriptome sequencing (Coleman *et al*. [2010](#age12857-bib-0043){ref-type="ref"}, [2013b](#age12857-bib-0045){ref-type="ref"}) and gene annotations (Hestand *et al*. [2015](#age12857-bib-0097){ref-type="ref"}; Balmer *et al*. [2017](#age12857-bib-0010){ref-type="ref"}; Mansour *et al*. [2017](#age12857-bib-0156){ref-type="ref"}), have revealed several inconsistencies in the assembly. Therefore, taking advantage of new genomic technologies, the genome of *Twilight* was recently re‐sequenced and assembled, resulting in EquCab3.0 (Kalbfleisch *et al*. [2018](#age12857-bib-0116){ref-type="ref"}). The new assembly was built upon the solid foundation of EquCab2.0 (Wade *et al*. [2009](#age12857-bib-0282){ref-type="ref"}), physical maps (Raudsepp *et al*. [2008](#age12857-bib-0217){ref-type="ref"}) and BAC end sequences (Leeb *et al*. [2006](#age12857-bib-0132){ref-type="ref"}). These were augmented with 45‐fold short‐read data that improved the accuracy of unique regions of the genome. Chromosome length scaffolding was achieved by including Chicago^®^ and Hi‐C proximity ligation data and 16‐fold long‐read Pacific Biosciences (PacBio) data.

The new assembly improved both the contiguity and composition of the horse reference genome. For example, the number of gaps was reduced 10‐fold, from 55 Mb (2.2% of the genome) in EquCab2.0 to 9 Mb (0.34% of the genome) in EquCab3.0, and the number of assembled bases in the incorporated chromosomes improved from 2.33 to 2.41 Gb (3% increase). Contiguity improved nearly 40‐fold and it is noteworthy that only ECA6 comprises two scaffolds; all other chromosomes comprise a single scaffold. In addition, the use of the Chromium 10X platform allowed for true haplotype phasing, so the final assembly has the most common and likely ancestral allele at each heterozygous site. Comparison of EquCab2.0 and EquCab3.0 mapping statistics for 13 previously published ancient DNA samples (Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}; Librado *et al*. [2015](#age12857-bib-0139){ref-type="ref"}, [2017](#age12857-bib-0141){ref-type="ref"}; Gaunitz *et al*. [2018](#age12857-bib-0080){ref-type="ref"}) showed that significantly more reads mapped to the new assembly, demonstrating its improved utility for the mapping of highly fragmented and damaged DNA samples.

Table [1](#age12857-tbl-0001){ref-type="table"} demonstrates that the size and gene content of the reference genome have marginally but consistently increased for all chromosomes. The exception is ECA5, which is smaller and has fewer genes in EquCab3.0 than in EquCab2.0, most likely owing to inconsistencies in the previous assembly. Two chromosomes, ECA12 and ECAX, increased in length by almost 4 Mb owing to incorporating previously unplaced contigs, and the number of annotated, non‐coding genes has essentially increased for all chromosomes. This is probably due to improved sequence composition and better annotation pipelines, although detailed annotation of the horse genome will be the task of the ongoing Functional Annotation of ANimal Genomes (FAANG) project (described in detail below). The necessary prerequisite for FAANG is a high‐quality and contiguity reference genome (Andersson *et al*. [2015](#age12857-bib-0005){ref-type="ref"}), and EquCab3.0 serves this purpose. Nevertheless, EquCab3.0 is also a tribute to EquCab2.0 and testimony that the first Sanger assembly of the *Twilight* genome 10 years ago was an outstanding achievement, providing the foundation for answering genetic questions related to the horse.

###### 

Chromosome‐wise comparison of EquCab2.0 and EquCab3.0.

  Horse chromosome                                Size, Mb   Protein coding genes   Non‐coding genes                   
  ----------------------------------------------- ---------- ---------------------- ------------------ -------- ------ ------
  ECA1                                            185.8      188.3                  1656               1683     166    705
  ECA2                                            120.9      121.4                  1062               1077     103    450
  ECA3                                            119.5      121.4                  838                883      79     391
  ECA4                                            108.6      109.5                  750                735      90     354
  ECA5                                            99.7       96.8                   1004               999      99     322
  ECA6                                            84.7       87.2                   962                988      63     326
  ECA7                                            98.5       100.8                  1236               1367     86     386
  ECA8                                            94.1       97.6                   714                773      69     397
  ECA9                                            83.6       85.8                   451                447      39     296
  ECA10                                           84.0       85.2                   1032               1146     61     346
  ECA11                                           61.3       61.7                   1086               1141     109    282
  ECA12                                           33.1       37.0                   639                738      34     177
  ECA13                                           42.6       43.8                   657                711      44     175
  ECA14                                           94.0       94.6                   665                693      63     368
  ECA15                                           91.6       92.9                   659                664      54     376
  ECA16                                           87.4       89.0                   683                713      73     299
  ECA17                                           80.8       80.7                   352                338      44     288
  ECA18                                           82.5       82.6                   422                416      62     259
  ECA19                                           60.0       62.7                   407                418      47     208
  ECA20                                           64.2       65.3                   709                738      50     262
  ECA21                                           57.7       59.0                   376                388      37     199
  ECA22                                           49.9       50.9                   533                560      53     244
  ECA23                                           55.7       55.6                   296                294      53     251
  ECA24                                           46.7       48.3                   381                453      141    298
  ECA25                                           39.5       40.3                   523                554      42     160
  ECA26                                           41.9       43.1                   221                232      19     129
  ECA27                                           40.0       40.3                   215                232      20     110
  ECA28                                           46.2       47.3                   383                388      46     189
  ECA29                                           33.7       34.8                   181                170      25     156
  ECA30                                           30.1       31.4                   171                185      20     104
  ECA31                                           25.0       26.0                   140                154      13     86
  ECAX                                            124.1      128.2                  853                821      151    371
  ECAY[^1^](#age12857-note-0002){ref-type="fn"}   n/a        9.5                    n/a                52              n/a
  Total                                           2440.8     2419                   15 428             21 151   2055   8964

Ensembl: <http://www.ensembl.org/index.html> for assembly size and annotated gene content.

Y chromosome data are from Janečka *et al*. ([2018](#age12857-bib-0111){ref-type="ref"}).
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Unique features of horse centromeres {#age12857-sec-0005}
------------------------------------

Centromeres are typically not part of reference genomes because they are composed of arrays of nearly identical tandem repeats, known as satellite DNA, and are extremely difficult to assemble even with long‐read sequencing technologies (Miga *et al*. [2014](#age12857-bib-0176){ref-type="ref"}; Jain *et al*. [2018](#age12857-bib-0110){ref-type="ref"}). An outstanding exception is horse ECA11, which has no satellite DNA and is the first sequenced example of a natural satellite‐free and evolutionary 'immature' centromere (Wade *et al*. [2009](#age12857-bib-0282){ref-type="ref"}; Wade [2013](#age12857-bib-0281){ref-type="ref"}). This unusual and most interesting discovery led to in‐depth studies of centromeres in horses and equids. Three centromere satellite families, 37cen, 2PI and EC137, have been isolated, characterized and localized in horse and equid chromosomes, revealing that in donkeys and zebras a large number of centromeres lack satellite DNA (Piras *et al*. [2010](#age12857-bib-0211){ref-type="ref"}; Nergadze *et al*. [2014](#age12857-bib-0185){ref-type="ref"}). With the help of chromatin immunoprecipitation sequencing (ChIP‐seq) methodology, it was shown that 37cen satellite binds to the centromeric histone H3 variant CENPA protein, is transcriptionally active and probably required for centromere function (Cerutti *et al*. [2016](#age12857-bib-0036){ref-type="ref"}). However, further studies of satellite‐free horse ECA11 revealed that centromere is defined epigenetically by binding of the CENPA protein and not by the presence of satellite repeats (Purgato *et al*. [2015](#age12857-bib-0214){ref-type="ref"}). Interestingly, the size and exact location of the approximately 100 kb (kilo‐base) CENPA binding region differ between individuals, giving rise to epialleles, a phenomenon known as centromere sliding (Purgato *et al*. [2015](#age12857-bib-0214){ref-type="ref"}; Giulotto *et al*. [2017](#age12857-bib-0087){ref-type="ref"}). These observations were further strengthened by a study of donkey centromeres (Nergadze *et al*. [2018](#age12857-bib-0186){ref-type="ref"}). The donkey genome has 16 chromosomes with satellite‐free centromeres, which is perfectly compatible with genome stability and species survival. Analysis of the transmission of CENPA‐binding epialleles in mules and hinnies shows that centromeric domains are inherited as Mendelian traits, although centromere sliding can happen in one generation. Overall, the discovery of satellite‐free centromeres in horses and equids has provided a unique model for the study of the evolution, dynamics and molecular regulation of mammalian centromeres.

The Y chromosome {#age12857-sec-0006}
----------------

The female‐based horse reference genome is incomplete because it does not include the Y chromosome. It is therefore noteworthy that, concurrently with the release of EquCab3.0 (Kalbfleisch *et al*. [2018](#age12857-bib-0116){ref-type="ref"}), the first comprehensive assembly and annotation of the male‐specific region of the horse Y (MSY) was published (Janečka *et al*. [2018](#age12857-bib-0111){ref-type="ref"}). The 9.5 Mb assembly represents the Y chromosome of a Thoroughbred stallion *Bravo*, a half‐brother of *Twilight*, thus completing the Thoroughbred‐based horse reference genome. The assembly provides information about the horse Y chromosome organization, sequence classes and gene content (52 genes and 174 transcripts). Notably, the study identified a novel testis‐expressed XY ampliconic sequence class *ETSTY7*, which is shared with the parasite *Parascaris* genome, providing evidence for eukaryotic horizontal gene transfer. Alignment of MSY assembly with horse, donkey and mule testis transcriptome data suggests candidate genes for stallion fertility. The MSY assembly provides a needed reference toward improved understanding for the role of the Y chromosome in equine male development and fertility.

Another keen interest in the male‐specific and non‐recombining Y chromosome is its inheritance exclusively through male lineages. This makes Y chromosome sequence polymorphisms excellent markers for tracing the patriline history of ancient horses and modern breeds. However, until recently, the main problem with the horse Y chromosome was the lack of sequence polymorphism (Lindgren *et al*. [2004](#age12857-bib-0142){ref-type="ref"}; Wallner *et al*. [2004](#age12857-bib-0284){ref-type="ref"}; Brandariz‐Fontes *et al*. [2013](#age12857-bib-0030){ref-type="ref"}), suggesting a limited number of patrilines in horse domestication and omitting the use of the Y to trace those patrilines. Even though one polymorphic microsatellite, *YA16*, with two alleles was detected in a few individuals of indigenous Chinese horses (Ling *et al*. [2010](#age12857-bib-0144){ref-type="ref"}), no variants were found in other modern breeds. In contrast, sequencing just a 4 kb Y chromosome fragment from eight ancient horses revealed 28 segregating sites and eight haplotypes (Lippold *et al*. [2011](#age12857-bib-0145){ref-type="ref"}), demonstrating considerable diversity in the ancestral horse Y and the loss of this diversity during domestication. Nevertheless, persistent search, combined with the use of high‐throughput next‐generation sequencing technologies, led to step‐wise discovery of a limited number of variable sites also in the modern horse Y chromosome. These included two SNPs that defined six Y haplotypes in modern breeds (Wallner *et al*. [2013](#age12857-bib-0285){ref-type="ref"}), and two microsatellites---*YP9* in Hucul and Mongolian horses and *YN04* in a Shetland pony (Kreutzmann *et al*. [2014](#age12857-bib-0122){ref-type="ref"}). This small but significant progress led to more systematic discoveries of Y chromosome variants based on WGS and MSY assembly. Fifty‐three variants (50 SNPs and three indels) and 24 haplotypes were identified from a 1.46 Mb MSY sequence of 52 males of 21 different breeds (Wallner *et al*. [2017](#age12857-bib-0286){ref-type="ref"}), followed by the description of another 211 variants and 58 haplotypes by screening 5.8 Mb of MSY in 130 horses of rural breeds and nine Przewalski\'s horses (Felkel *et al*. [2019](#age12857-bib-0067){ref-type="ref"}). This is an awaited breakthrough in horse Y chromosome research and has already launched a number of studies to determine the time and cause(s) of the loss of Y variation (Wutke *et al*. [2018](#age12857-bib-0299){ref-type="ref"}), as well as enabling the tracing of patrilines of modern breeds and pedigrees (Wallner *et al*. [2017](#age12857-bib-0286){ref-type="ref"}; Felkel *et al*. [2018](#age12857-bib-0066){ref-type="ref"}, [2019](#age12857-bib-0067){ref-type="ref"}; Kakoi *et al*. [2018](#age12857-bib-0115){ref-type="ref"}; Khaudov *et al*. [2018](#age12857-bib-0118){ref-type="ref"}; Han *et al*. [2019](#age12857-bib-0093){ref-type="ref"}).

Recent studies of ancient samples provide clues about when and why the horse Y chromosome lost its genetic diversity. A study of four MSY polymorphic markers in 96 ancient stallions from early domestication indicates that the reduction of Y diversity over time was not due to genetic drift or founder effect, but the result of artificial selection that started during the Iron Age and continued during the Roman period (Wutke *et al*. [2018](#age12857-bib-0299){ref-type="ref"}). This is supported and further elaborated by a more extensive study involving 105 ancient stallions and over 1500 polymorphic MSY sites showing that Y chromosome nucleotide diversity decreased steadily during the last approximately 2000 years but dropped to present levels only after 850--1350 AD (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"})

Genomics tools and resources {#age12857-sec-0007}
============================

SNP genotyping array {#age12857-sec-0008}
--------------------

The most impactful tool and resource for horse genomics has certainly been the reference genome. As noted, EquCab2.0 has been the critical template for the discovery of millions of sequence polymorphisms from diverse horse breeds, leading to the development of three generations of SNP chips which have been utilized to map traits and understand breed diversity and signatures of selection. First‐ and second‐generation DNA genotyping arrays, containing 54 602 and 74 500 SNP markers, respectively, became available in 2011 (reviewed in Finno & Bannasch [2014](#age12857-bib-0068){ref-type="ref"}). A number of phenotypic traits of interest and disease traits were identified using these arrays, including Lavender Foal Syndrome (Brooks *et al*. [2010](#age12857-bib-0032){ref-type="ref"}), alternate gait (Andersson *et al*. [2012](#age12857-bib-0004){ref-type="ref"}), iris color variation (Mack *et al*. [2017](#age12857-bib-0154){ref-type="ref"}) and ocular squamous cell carcinoma (Bellone *et al*. [2017](#age12857-bib-0017){ref-type="ref"}; Tables [2](#age12857-tbl-0002){ref-type="table"} and [3](#age12857-tbl-0003){ref-type="table"}). Additionally, these resources were used to identify breed specific signatures of selection (Petersen *et al*. [2013b](#age12857-bib-0206){ref-type="ref"}) that aid in our understanding of the biology behind performance and other selected traits in the horse (Andersson *et al*. [2012](#age12857-bib-0004){ref-type="ref"}; Petersen *et al*. [2014b](#age12857-bib-0208){ref-type="ref"}).

###### 

Genetic variants identified for traits influencing pigmentation.

  Phenotype                                                                    Gene               *Allele*            Type of variant                         Chromosome   Breed                                                                                                                                          Year published   PubMed ID
  ---------------------------------------------------------------------------- ------------------ ------------------- --------------------------------------- ------------ ---------------------------------------------------------------------------------------------------------------------------------------------- ---------------- ----------------------------------------------------
  Chestnut                                                                     *MC1R*             *e*                 Missense                                3            Many                                                                                                                                           1996             8995760
  **Frame overo (Lethal White Foal Syndrome, LWFS)**                           ***EDNRB***        ***O***             **Missense**                            **17**       **American Paint Horse, Miniature Horse, Pinto Horse, Quarter Horse Thoroughbred, Appaloosa**                                                  **1998**         **9530628**
  Chestnut                                                                     *MC1R*             *e* ^*a*^           Missense                                3            Black Forest                                                                                                                                   2000             11086549
  Recessive black                                                              *ASIP*             *a*                 11 bp deletion                                       Many                                                                                                                                           2001             11353392
  Cream dilution                                                               *SLC45A2*          *C* ^*Cr*^          Missense                                21           Many                                                                                                                                           2003             12605854
  Sabino 1                                                                     *KIT*              *SB1*               Splicing                                3            Appaloosa, Haflinger, Lipizzan, Noriker, Quarter Horse                                                                                         2005             16284805
  **Silver (Multiple Congenital Ocular Anomalies, MCOA)**                      *PMEL*             *Z*                 Missense                                             American Miniature Horse, Icelandic Rocky Mountain, Kentucky Mountain Horse                                                                    2006             17029645
  Tobiano                                                                      *KIT* (proposed)   *To*                \~43 Mb inversion                       3            Many                                                                                                                                           2007             18253033
  Dominant white                                                               *KIT*              *W1*                Nonsense (stop‐gain)                    3            Franches‐Montagnes                                                                                                                             2007             17997609
  Dominant white                                                               *KIT*              *W2*                Missense                                3            Thoroughbred                                                                                                                                   2007             17997609
  Dominant white                                                               *KIT*              *W4*                Missense                                3            Camarillo White Horse                                                                                                                          2007             17997609
  Dominant white                                                               *KIT*              *W3*                Nonsense (stop‐gain)                    3            Arabian                                                                                                                                        2007             17997609
  **Grey (melanoma susceptibility)**                                           *STX17*            *G*                 4.6 kb intronic duplication             25           Many                                                                                                                                           2008             18641652
  Champagne dilution                                                           *SLC36A1*          *Ch*                Missense                                14           Spanish Mustang, Tennessee Walking Horse, Quarter Horse, and pony breeds                                                                       2008             18802473
  Dominant white                                                               *KIT*              *W11*               Splicing                                3            South German Draft                                                                                                                             2009             19456317
  Dominant white                                                               *KIT*              *W8*                Splicing                                3            Icelandic                                                                                                                                      2009             19456317
  Dominant white                                                               *KIT*              *W7*                Splicing                                3            Thoroughbred                                                                                                                                   2009             19456317
  Dominant white                                                               *KIT*              *W5*                1 bp deletion, frameshift               3            Thoroughbred                                                                                                                                   2009             19456317
  Dominant white                                                               *KIT*              *W9*                Missense                                3            Holstein                                                                                                                                       2009             19456317
  Dominant white                                                               *KIT*              *W10*               4 bp deletion, frameshift               3            Quarter Horse                                                                                                                                  2009             19456317
  Dominant white                                                               *KIT*              *W6*                Missense                                3            Thoroughbred                                                                                                                                   2009             19456317
  **Lavender foal syndrome**                                                   ***MYO5A***        ***LFS***           **1 bp deletion, frameshift**                        **Arabian**                                                                                                                                    **2010**         **20419149**
  Dominant white                                                               *KIT*              *W12*               5 bp deletion                           3            Thoroughbred                                                                                                                                   2010             <https://doi.org/10.1111/j.1365-2052.2010.02135.x>
  Dominant white                                                               *KIT*              *W13*               Splicing                                3            American Miniature Horse, Quarter Horse                                                                                                        2011             21554354
  Dominant white                                                               *KIT*              *W16*               Missense                                3            Oldenburg                                                                                                                                      2011             21554354
  Dominant white                                                               *KIT*              *W14*               54 bp deletion                          3            Thoroughbred                                                                                                                                   2011             21554354
  Dominant white                                                               *KIT*              *W17b*              Missense                                3            Japanese Draft                                                                                                                                 2011             21554354
  Dominant white                                                               *KIT*              *w17a*              Missense                                3            Japanese Draft                                                                                                                                 2011             21554354
  Dominant white                                                               *KIT*              *W15*               Missense                                3            Arabian                                                                                                                                        2011             21554354
  Macchiato                                                                    *MITF*             *macchiato*         Missense                                16           Franches‐Montagnes                                                                                                                             2012             22511888
  Splashed white                                                               *MITF*             *SW3*               5 bp deletion, frameshift               16           Quarter Horse                                                                                                                                  2012             22511888
  Splashed white                                                               *MITF*             *SW1*               Insertion 11 bp, regulatory             16           American Miniature Horse, American Paint Horse, Appaloosa, Icelandic, Morgan, Old‐Tori, Quarter Horse, Shetland Pony, Trakehner                2012             22511888
  Splashed white                                                               *PAX3*             *SW2*               Missense                                6            Lipizzan, Noriker, Quarter Horse                                                                                                               2012             22511888
  Dominant white                                                               *KIT*              *W18*               Splicing                                3            Swiss Warmblood                                                                                                                                2013             23659293
  Dominant white                                                               *KIT*              *W20*               Missense                                3            American Paint Horse, Appaloosa, German Riding Pony, Gipsy, Noriker, Old‐Tori, Oldenburg, Quarter Horse, Thoroughbred, Warmblood, Welsh Pony   2013             23659293
  Dominant white                                                               *KIT*              *W19*               Missense                                3            Arabian                                                                                                                                        2013             23659293
  Splashed white                                                               *PAX3*             *SW4*               Missense                                6            Appaloosa                                                                                                                                      2013             23659293
  **Leopard Complex Spotting (Congenital Stationary Night Blindness, CSNB)**   *TRPM1*            *LP*                Insertion 1378 bp                       1            American Miniature Horse, Appaloosa, Australian Spotted Pony, British Spotted Pony, Knabstrupper, Noriker, Pony of the Americas,               2013             24167615
  **Brindle (** ***Incontinentia pigmenti*** **)**                             *IKBKG*                                Nonsense (stop‐gain)                    X            Quarter Horse                                                                                                                                  2013             24324710
  Dominant white                                                               *KIT*              *W21*               1 bp deletion, frameshift               3            Icelandic                                                                                                                                      2015             26059442
  Non‐dun with primitive markings                                              *TBX3*             *nd1*               Regulatory                              8            Many                                                                                                                                           2016             26691985
  Non‐dun                                                                      *TBX3*             *nd2*               1609‐bp and 8‐bp deletion, regulatory   8            Many                                                                                                                                           2016             26691985
  LP pattern modifier                                                          *RFWD3*            *PATN1*             Regulatory                              3            American Miniature Horse, Appaloosa, Australian Spotted Pony, British Spotted Pony, Knabstrupper, Noriker, Pony of the Americas                2016             26568529
  Brindle 1                                                                    *MBTPS2*           *Br1*               Splicing                                             Quarter Horse                                                                                                                                  2016             27449517
  White                                                                        *MITF*             *MITF* ^*244Glu*^   Missense                                16           American Standardbred                                                                                                                          2017             27592871
  White leg markings                                                           *MITF*                                 Regulatory                              16           Menorca Purebred                                                                                                                               2017             28084638
  Dominant white                                                               *KIT*              *W23*               Splicing                                3            Arabian                                                                                                                                        2017             28378922
  Dominant white                                                               *KIT*              *W22*               Deletion 1898 bp                        3            Thoroughbred                                                                                                                                   2017             28444912
  Tiger eye                                                                    *SLC24A5*          *TE2*               Deletion 626 bp                         1            Paso Fino                                                                                                                                      2017             28655738
  Tiger eye                                                                    *SLC24A5*          *TE1*               Missense                                1            Paso Fino                                                                                                                                      2017             28655738
  Dominant white                                                               *KIT*              *W24*               Splicing                                3            Italian Trotter                                                                                                                                2017             28856698
  Dominant white                                                               *KIT*              *W27*               Missense                                3            Thoroughbred                                                                                                                                   2018             29333746
  Dominant white                                                               *KIT*              *W26*               1 bp deletion, frameshift               3            Thoroughbred                                                                                                                                   2018             29333746
  Dominant white                                                               *KIT*              *W25*               Missense                                3            Thoroughbred                                                                                                                                   2018             29333746
  Curly coat                                                                   *KRT25*            *Crd*               Missense                                11           Bashkir Curly Horse                                                                                                                            2018             29686323 29141579
  **Splashed white, blue eyes and deafness**                                   *MITF*             *SW5*               63 kb deletion                          16           American Paint Horse                                                                                                                           2019             30644113
  Pearl dilution                                                               *SLC45A2*          *C* ^*prl*^         Missense                                21           American Paint Horse, Lusitano, Purebred Spanish horse, Quarter Horse                                                                          2019             31006892, 30968968
  Sunshine dilution                                                            *SLC45A2*          *C* ^*sun*^         Missense                                21           Standardbred × Tennessee Walking Horse cross                                                                                                   2019             31006892

Variants influencing pigmentation with known pleiotropic effects are in bold; details for genomic, coding and protein coordinates are in [Table S1](#age12857-sup-0001){ref-type="supplementary-material"}.

John Wiley & Sons, Ltd

###### 

Genetic variants underlying disease and performance traits in the horse.

  Disease                                                                      Gene          Type of variant                                            Mode of Inheritance     Chromosome    Breed                                                                                                Year published   PubMed ID
  ---------------------------------------------------------------------------- ------------- ---------------------------------------------------------- ----------------------- ------------- ---------------------------------------------------------------------------------------------------- ---------------- ----------------------------
  Hyperkalemic periodic paralysis                                              *SCN4A*       Missense                                                   Dominant                11            American Quarter Horse and related breeds                                                            1992             1338908
  Ovotesticular disorder of sexual development (DSD)                           *SRY*         Large deletion of the DNA‐binding domain of the SRY gene   Y‐linked                Y             Standardbred                                                                                         1995             7558880
  Severe combined immunodeficiency disease (SCID)                              *PRKDC*       Deletion 5 bp                                              Recessive               9             Arabian                                                                                              1997             9103416
  Junctional epidermolysis bullosa (JEB1)                                      *LAMC2*       Insertion 1 bp                                             Recessive               5             Belgian and Italian draft horse                                                                      2002             12230513
  Malignant hyperthermia (MH)                                                  *RYR1*        Missense                                                   Dominant                10            American Quarter Horse                                                                               2004             15318347
  Glycogen branching enzyme deficiency (GBED)                                  *GBE1*        Nonsense (stop‐gain)                                       Recessive               26            American Quarter Horse and related breeds                                                            2004             15366377
  Thrombasthenia                                                               *ITGA2B*      Missense                                                   Recessive               11            American Quarter Horse & Thoroughbred                                                                2006             16407493
  Thrombasthenia                                                               *ITGA2B*      Deletion 10 bp                                             Recessive               11            American Quarter Horse                                                                               2007             17338169
  Hereditary equine regional dermal asthenia (HERDA)                           *PPIB*        Missense                                                   Recessive               1             American Quarter Horse                                                                               2007             17498917
  Polysaccharide storage myopathy (PSSM1)                                      *GYS1*        Missense                                                   Incompletely dominant   10            American Quarter Horse, American Paint Horse, Appaloosa, Draft, Pony of the America, and Warmblood   2008             18358695
  Junctional epidermolysis bullosa (JEB2)                                      *LAMA3*       Deletion 6589 bp                                           Recessive               5             American Saddlebred                                                                                  2009             19016681
  Racing distance                                                              *MSTN*        Insertion 227 bp, regulatory                                                       18            Thoroughbred                                                                                         2010             20098749 25160752 30379863
  Cerebellar abiotrophy (CA)                                                   *MUTYH*       Regulatory                                                 Recessive               2             Arabian, Bashkir Curly Horse, Danish Sport Horse, Trakehner, and Welsh Pony                          2011             21126570 and 29103988
  Foal immunodeficiency syndrome in the Fell and Dales pony (FIS)              *SLC5A3*      Missense                                                   Recessive               26            Dales Pony and Fell Pony                                                                             2011             21750681
  Androgen insensitivity syndrome (AIS)                                        *AR*          Regulatory                                                 X linked                X             American Quarter Horse                                                                               2012             22095250
  Myotonia                                                                     *CLCN1*       Missense                                                   Recessive               4             New Forest Pony                                                                                      2012             22197188
  Permissive to gait                                                           *DMRT3*       Nonsense (stop‐gain)                                       Dominant                23            Numerous breeds                                                                                      2012             22932389
  Warmblood fragile foal syndrome (WFFS) or Ehlers--Danlos syndrome, type VI   *PLOD1*       Missense                                                   Recessive               2             Warmblood                                                                                            2015             25637337
  Hoof wall separation syndrome                                                *SERPINB11*   Insertion 1 bp                                             Recessive               8             Connemara                                                                                            2015             25875171
  Hydrocephalus                                                                *B3GALNT2*    Nonsense (stop‐gain)                                       Recessive               1             Friesian                                                                                             2015             26452345
  Androgen insensitivity syndrome (AIS)                                        *AR*          Missense                                                   X linked                X             Thoroughbred                                                                                         2016             27073903
  Skeletal atavism                                                             *SHOX*        2 over lapping deletions 160 = 180 kb and 60--80 kb        Recessive               X and Y PAR   Shetland                                                                                             2016             27207956
  Dwarfism, Friesian                                                           *B4GALT7*     Missense                                                   Recessive               14            Friesian                                                                                             2016             27793082
  Dwarfism, ACAN‐related D3\*                                                  *ACAN*        Missense                                                   Recessive               1             Miniature Shetland                                                                                   2017             27942904
  Occipitoatlantoaxial malformation (OAAM)                                     *HOXD3*       Deletion 2.7 kb                                            Recessive               18            Arabian                                                                                              2017             28111759
  Androgen insensitivity syndrome (AIS)                                        *AR*          Deletion 25 bp                                             X linked                X             Warmblood                                                                                            2017             28192783
  Naked foal syndrome                                                          *ST14*        Nonsense (stop‐gain)                                       Recessive               7             Akhal‐Teke                                                                                           2017             28235824
  Ocular squamous cell carcinoma (ocular SCC)                                  *DDB2*        Missense                                                   Recessive               12            Belgian, Haflinger, Percheron, Rocky Mountain Horse                                                  2017             28425625
  Immune‐mediated myositis (IMM/MYH1)                                          *MYH1*        Missense                                                   Recessive               11            American Quarter Horse                                                                               2018             29510741
  Curly coat with hypotrichosis Crd                                            *KRT25*       Missense                                                   Dominant                11            Bashkir Curly Horse                                                                                  2018             29686323 29141579
  Curly coat without hypotrichosis                                             *SP6*         Missense                                                   Dominant                11            American Bashkir Curly Horse and Missouri Foxtrotter                                                 2018             29686323
  Dwarfism, ACAN‐related D4                                                    *ACAN*        Deletion 42 bp                                             Recessive               1             Miniature                                                                                            2018             30058072
  Dwarfism, ACAN‐related D2                                                    *ACAN*        Missense                                                   Recessive               1             Miniature                                                                                            2018             30058072
  Dwarfism, ACAN‐related D1                                                    *ACAN*        Deletion 1 bp                                              Recessive               1             Miniature                                                                                            2018             30058072

Genomic, coding and protein sequence coordinates are in [Table S2](#age12857-sup-0002){ref-type="supplementary-material"}.

John Wiley & Sons, Ltd

In 2017, a third‐generation SNP array was developed containing 670 805 SNP markers (MNEc670k array, Affymetrix; Schaefer *et al*. [2017](#age12857-bib-0232){ref-type="ref"}). This array was designed using WGS from 156 horses representing 24 distinct breeds. Mean inter‐SNP distance was estimated at 3756 bp with SNP selection aimed at tagging approximately 2 million SNPs. To date, two published studies have successfully mapped traits with the 670K array, followed by fine‐mapping with WGS. The first identified a nonsense variant in *ST14* associated with Naked Foal Syndrome in the Akhal‐Teke (Bauer *et al*. [2017](#age12857-bib-0013){ref-type="ref"}) and the second identified genetic variants in two genes, *KRT25* and *SP6*, responsible for a curly coat in horses (Thomer *et al*. [2018](#age12857-bib-0266){ref-type="ref"}).

With the recently updated reference assembly of the equine genome (Kalbfleisch *et al*. [2018](#age12857-bib-0116){ref-type="ref"}), the SNP array coordinates were remapped to EquCab3.0 (Beeson *et al*. [2019](#age12857-bib-0014){ref-type="ref"}). The raw reports with EquCab3.0 SNP coordinates for the MNEc670k array are hosted at <https://www.animalgenome.org/repository/pub/UMN2018.1003/>. Furthermore, coordinates between the two assemblies can be easily converted now at NCBI: <https://www.ncbi.nlm.nih.gov/genome/tools/remap>. The high‐density SNP array resource is undoubtedly aiding in the mapping of other important traits and we anticipate a continued increase in the number of discoveries made possible.

WGSs of individual horses {#age12857-sec-0009}
-------------------------

As next‐generation sequencing continues to become more affordable, WGSs of horses are being generated worldwide. At the time of this writing, 1936 public WGSs are available for the horse through the NCBI Sequence Read Archive (<https://www.ncbi.nlm.nih.gov/sra>). This tremendous resource provides investigators with a database of horse genomes to screen potential variants, and with the continuing addition of phenotypic metadata, this resource will facilitate future studies for many years to come.

WGSs are often used to identify putative genetic variants within regions identified by GWAS. Two recent examples include the discovery of the splice site mutation in *B4GALT7* associated with dwarfism and joint laxity in Friesian horses (Leegwater *et al*. [2016](#age12857-bib-0133){ref-type="ref"}). Using the first‐generation SNP array (\~50K markers), a region on ECA14 was initially identified by GWAS. Four dwarf cases and three unrelated controls then underwent WGS. Pooling data from the four cases and variant calling identified the putative variant in *B4GALT7*, later confirmed via Sanger sequencing and demonstrated to affect splicing through analysis of cDNA from affected horses. Notably, this is the second gene with a role in protein glycosylation in which a pathogenic mutation has been identified in Friesian horses. A nonsense mutation in *B3GALNT2* involved in muscular dystrophy with hydrocephalus in stillborn foals was discovered previously by the same group using similar techniques (Ducro *et al*. [2015](#age12857-bib-0060){ref-type="ref"}). This approach was also utilized to unravel the genetic mutation responsible for both immune‐mediated myositis (Finno *et al*. [2018](#age12857-bib-0072){ref-type="ref"}) and non‐exertional rhabdomyolysis (Valberg *et al*. [2018](#age12857-bib-0273){ref-type="ref"}) in the Quarter Horse as well as congenital hepatic fibrosis in the Swiss Franches‐Montagnes (Drogemuller *et al*. [2014](#age12857-bib-0059){ref-type="ref"}).

Many recently discovered, potential causal genetic variants in the horse have been identified through WGS alone. Public WGS was screened for putative deleterious variants associated with stallion infertility and further evaluated in a group of 337 fertile stallions across 19 breeds (Schrimpf *et al*. [2016](#age12857-bib-0235){ref-type="ref"}). A variant in *NOTCH1* (g.37455302G\>A) was identified as a significant stallion fertility locus in Hanoverian stallions. Additionally, nine candidate fertility loci with missing homozygous mutant genotypes were validated. WGS has recently identified a genetic cause of occipitoatlantoaxial malformation in an Arabian horse (Bordbari *et al*. [2017](#age12857-bib-0026){ref-type="ref"}) and dwarfism in a Miniature Shetland pony (Metzger *et al*. [2017](#age12857-bib-0173){ref-type="ref"}). WGS data have also been used to identify novel pigmentation variants (Henkel *et al*. [2019](#age12857-bib-0096){ref-type="ref"}). Finally, WGS has been used to investigate the characteristics of highly selected breeds (Metzger *et al*. [2014](#age12857-bib-0171){ref-type="ref"}).

With the continued reduction in the cost of WGS, we can expect to soon see many more publicly available genomes for the horse. The beauty of this resource is that, once available, the data can be used for diverse projects worldwide.

Other tools {#age12857-sec-0010}
-----------

In the past 10 years, several other array platforms have been generated to study the horse genome. On the basis of EquCab2.0, an exon array (Doan *et al*. [2012](#age12857-bib-0058){ref-type="ref"}) and two whole genome tiling arrays (Ghosh *et al*. [2014](#age12857-bib-0083){ref-type="ref"}; Wang *et al*. [2014](#age12857-bib-0288){ref-type="ref"}) were constructed for the discovery of CNVs. However, in a short time, these platforms have given way to more comprehensive WGSs. Likewise, cDNA and oligonucleotide microarrays, developed for gene expression studies (reviewed by Coleman *et al*. [2013a](#age12857-bib-0044){ref-type="ref"}), have been completely replaced by RNA‐seq. Nevertheless, a few genomics resources from the past, such as the genomic BAC library CHORI‐241 (<https://bacpacresources.org/>), remain in use in the post‐genome era. End sequences of CHORI‐241 BAC clones (Leeb *et al*. [2006](#age12857-bib-0132){ref-type="ref"}) helped to validate the EquCab3.0 assembly (Kalbfleisch *et al*. [2018](#age12857-bib-0116){ref-type="ref"}); BAC tiling paths are used to re‐sequence complex genomic regions such as the terminal end of the pseudoautosomal region in ECAX (Rafati *et al*. [2016](#age12857-bib-0215){ref-type="ref"}) and the male‐specific region of ECAY (Janečka *et al*. [2018](#age12857-bib-0111){ref-type="ref"}), and cytogenetic mapping of BAC clones is still a reliable method to validate copy number changes (Ghosh *et al*. [2014](#age12857-bib-0083){ref-type="ref"}; Staiger *et al*. [2016a](#age12857-bib-0250){ref-type="ref"}) and other large‐scale structural rearrangements.

Ancient genomics and natural history of the horse {#age12857-sec-0011}
=================================================

The assembly of the horse reference genome EquCab2.0 (Wade *et al*. [2009](#age12857-bib-0282){ref-type="ref"}), along with success in extracting and sequencing ancient genomic DNA (Orlando *et al*. [2011](#age12857-bib-0194){ref-type="ref"}), has essentially expanded our knowledge about the natural history of equids (Orlando *et al*. [2013](#age12857-bib-0195){ref-type="ref"}; Jonsson *et al*. [2014](#age12857-bib-0113){ref-type="ref"}), horse domestication and the dynamics of the horse genome over time, from the pre‐domestication era to the present (Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}; Librado *et al*. [2015](#age12857-bib-0139){ref-type="ref"}, [2017](#age12857-bib-0141){ref-type="ref"}; Gaunitz *et al*. [2018](#age12857-bib-0080){ref-type="ref"}; Janečka *et al*. [2018](#age12857-bib-0111){ref-type="ref"}; Wutke *et al*. [2018](#age12857-bib-0299){ref-type="ref"}; Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). The findings of ancient DNA studies were summarized and discussed in an excellent review by Librado *et al*. ([2016](#age12857-bib-0140){ref-type="ref"}). Therefore, here we highlight only the most notable discoveries and discuss the studies published since that review.

It is noteworthy that, with regards to ancient DNA, horses/equids have made history three times---by being the first and the oldest, and most recently, by spanning the largest time‐scale of ancient genome data among non‐human organisms (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). The first successful ancient DNA extraction and analysis ever was reported in 1984 from 150‐year‐old tissue from the extinct quagga (Higuchi *et al*. [1984](#age12857-bib-0098){ref-type="ref"}), preceding by a year the first human ancient DNA study from a 2400‐year‐old Egyptian Mummy (Pääbo [1985](#age12857-bib-0198){ref-type="ref"}). Likewise, to date the oldest genomic DNA sample which has been successfully sequenced is that of a 700 000‐year‐old Pleistocene horse (Orlando *et al*. [2011](#age12857-bib-0194){ref-type="ref"}, [2013](#age12857-bib-0195){ref-type="ref"}), exceeding the age of the oldest hominin genomic DNA extracted from 430 000‐year‐old bones from Sima de los Huesos (Meyer *et al*. [2016](#age12857-bib-0175){ref-type="ref"}). The current peak of ancient genomics of non‐human organisms, but perhaps not the limit, is a study tracking 5000 years of horse domestication based on genome‐scale data from 278 ancient animals (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}).

Horse ancestry and domestication {#age12857-sec-0012}
--------------------------------

Genomics‐based searches into the wild ancestry of the domestic horse and the origins of horse domestication have been ongoing for decades. Yet the answers have only recently started to emerge, largely thanks to the contribution of WGS from ancient equine samples (Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}; Librado *et al*. [2015](#age12857-bib-0139){ref-type="ref"}, [2016](#age12857-bib-0140){ref-type="ref"}; Gaunitz *et al*. [2018](#age12857-bib-0080){ref-type="ref"}; Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). These studies reveal that, in addition to the two extant horses, the domestic (*Equus caballus*) and the Przewalski\'s horse (*E. przewalskii*) (Der Sarkissian *et al*. [2015](#age12857-bib-0050){ref-type="ref"}), there existed other, now extinct, horse lineages at the time of early domestication. One lineage, that was initially identified from approximately 43 000‐ to 5000‐year‐old bones from the Holarctic region (Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}), extended to Southern Siberia (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). This lineage shares morphological similarities with an extinct horse described as *Equus lenensis* (Boeskorov *et al*. [2018](#age12857-bib-0023){ref-type="ref"}; Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). Recent mtDNA and Y haplotype analyses of an approximately 24 000‐year‐old specimen from the Tuva Republic suggest that there may have been another genetically divergent lineage of horses in Siberia and the New Siberian Islands, although the genetic contact between *E. lenensis* and this 'ghost' lineage remains unknown (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). Finally, Iberian samples from the third and early second millennia BCE, cluster separately from *E. caballus*,*E. przewalskii* and *E. lenensis*, have extremely divergent Y and mtDNA, and therefore suggest that there was a different, now extinct, horse lineage in Iberia during the early phase of horse domestication (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). Earlier it was reported that that the Holarctic horse (*E. lenensis*) contributed 12.9% to the genetic makeup of domestic horses (Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}). However, the most recent study of 278 ancient equids and modern horses shows that none of the above extinct horse lineages contributed significantly to modern horse diversity (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}).

Another question of interest is the genetic relationship between the two surviving horses---the domestic horse and the Przewalski\'s horse. Until recently, the overall consensus, based on modern and ancient WGS, was that the two are separate species, diverged approximately 45 000 years ago (Goto *et al*. [2011](#age12857-bib-0089){ref-type="ref"}; Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}; Der Sarkissian *et al*. [2015](#age12857-bib-0050){ref-type="ref"}), with extensive bi‐directional gene flow (Der Sarkissian *et al*. [2015](#age12857-bib-0050){ref-type="ref"}; Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}). All studies agree that the domestic horse is not a direct descendant of the Przewalski\'s horse (Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}). These views were recently shaken by a study of over 40 ancient horse genomes from Eurasia, providing striking evidence that the Przewalski\'s horse is not truly wild, but rather a feral horse descended from the horses domesticated by Botai culture some 5500 years ago (de Barros Damgaard *et al*. [2018](#age12857-bib-0012){ref-type="ref"}; Gaunitz *et al*. [2018](#age12857-bib-0080){ref-type="ref"}). At the same time, all studied domestic horses dated from 4000 years ago to present show only 2.7% Botai ancestry, suggesting they descended from a different lineage of wild horses that subsequently went extinct (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}).

Ancient DNA studies have also attempted to decipher, but have not completely resolved, the timeline and geography of horse domestication. Current archeological and DNA evidence suggests multiple sites of horse domestication of which the earliest (\~5000--5500 years ago) were in the Western Eurasian steppes: Botai culture in Northern Kazakhstan and the Pontic--Caspian steppe (Outram *et al*. [2009](#age12857-bib-0197){ref-type="ref"}; Warmuth *et al*. [2012](#age12857-bib-0290){ref-type="ref"}; Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}; Gaunitz *et al*. [2018](#age12857-bib-0080){ref-type="ref"}; Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}), followed by additional candidate sites in Iberia, Eastern Anatolia, Western Iran, Levant and Eastern Europe (Hungary; Gaunitz *et al*. [2018](#age12857-bib-0080){ref-type="ref"}). It is noteworthy that native breeds from the main domestication sites such as the Pontic--Caspian steppes still represent hotspots of genetic diversity for horses (Warmuth *et al*. [2011](#age12857-bib-0289){ref-type="ref"}; Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}). However, even though the main candidate sites for domestication have been identified, the geographic origins of the modern domestic horse remain unknown. Given that the ancient Botai and Iberian lineages did not contribute substantially to modern domesticates and the temporal origins of the modern horse are modeled within the third and fourth millennium BCE, future studies of this timeline in other candidate regions of early domestication are needed (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}).

Genetic cost of domestication {#age12857-sec-0013}
-----------------------------

Domestication reduces overall fitness, known as 'the genetic cost of domestication' (Lu *et al*. [2006](#age12857-bib-0149){ref-type="ref"}; Moyers *et al*. [2018](#age12857-bib-0182){ref-type="ref"}). However, because of the extinction of wild horses, it has been difficult to evaluate the extent of this cost for the horse. Once again, the major breakthrough came with ancient DNA sequencing, providing a comparison with horses predating domestication (Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}) and from early stages of domestication (Librado *et al*. [2017](#age12857-bib-0141){ref-type="ref"}; Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). Genetic changes associated with horse domestication can be summarized as follows:

*Extreme mitochondrial DNA (mtDNA) diversity*. Modern horses have high mtDNA diversity and lack phylogeographic mitochondrial structure, resulting in limited correspondence between mtDNA haplotypes, breeds and geography (Vila *et al*. [2001](#age12857-bib-0279){ref-type="ref"}; Achilli *et al*. [2012](#age12857-bib-0001){ref-type="ref"}; Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}). Sequencing horse genomes from early domestication sites show that similar mtDNA diversity was present in Scythian horses some 2300 years ago (Librado *et al*. [2017](#age12857-bib-0141){ref-type="ref"}) and perhaps even earlier. Mitochondrial Bayesian Skylines reconstructed from 211 mitochondrial genomes suggest horse demographic expansion about 4500 years ago (Gaunitz *et al*. [2018](#age12857-bib-0080){ref-type="ref"}; Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). Reasons for the lack of mitochondrial structure are thought to be many, including sex‐biased restocking from the wild and human management (Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}).*Extreme lack of Y chromosome diversity*. Contrasting the diversity of mtDNA, the Y chromosome of domestic horses has become almost homogeneous with just a few haplotypes segregating in modern populations (Wallner *et al*. [2017](#age12857-bib-0286){ref-type="ref"}; Wutke *et al*. [2018](#age12857-bib-0299){ref-type="ref"}). At the same time, Y sequences of ancient Scythian horses indicate that a large diversity of domestic male founders contributed to early domestication (Librado *et al*. [2017](#age12857-bib-0141){ref-type="ref"}). Thus, the observed decline in Y chromosome variation happened only in the past few thousand years, probably because of the human‐mediated reduction in the stallion population size and selective breeding (Librado *et al*. [2017](#age12857-bib-0141){ref-type="ref"}; Wutke *et al*. [2018](#age12857-bib-0299){ref-type="ref"}; Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}).*Genetic load*. As a side‐effect of human‐driven selective breeding, the genome of the domestic horse has an increased level of deleterious mutations compared with pre‐domestication genomes (Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}). However, as mutation load is also lower in early domesticates from ancient Sintashta and Scythia, the excess of deleterious mutations in present day horses is probably a consequence of the past 2300 years of selective breeding (Librado *et al*. [2017](#age12857-bib-0141){ref-type="ref"}), whereas the most striking changes have occurred during the past 200 years (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}).*Domestication‐associated genetic changes*. One of the first comparisons between ancient pre‐domestic horse genomes and those of modern breeds revealed 125 candidate genes that underwent episodes of positive selection during domestication (Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}). These include genes involved in the cardiac and circulatory system, bone, limb and face morphogenesis, brain development and behavior, and coat color (Schubert *et al*. [2014](#age12857-bib-0237){ref-type="ref"}; Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}). Genetic changes during horse domestication agree with the neural crest hypothesis and involve developmental changes affecting tissues and cell types of neural crest origin (Librado *et al*. [2017](#age12857-bib-0141){ref-type="ref"}). However, the genomic cost of domestication and modern breeding is best illustrated by a striking discovery of a recent comparative study of ancient and modern horse genomes, showing that early breeders managed to maintain genetic diversity for millennia after domestication, and that the genetic diversity of the modern horse has dropped by 16% during just the past 200 years (Fages *et al*. [2019](#age12857-bib-0064){ref-type="ref"}). It is not a coincidence that the last 200 years also cover the time of the development of horse breeds, the establishment of studbooks and the implementation of extensive selective breeding.

Genetic makeup of modern horse breeds {#age12857-sec-0014}
-------------------------------------

Since domestication, the genetic diversity present in ancient horse populations has been exploited for selective breeding for a wide range of phenotypes. However, the creation of the about 500 specialized horse populations or breeds by intense artificial selection and the establishment of (closed) studbooks happened only during the past 100--200 years (Hendricks [2007](#age12857-bib-0095){ref-type="ref"}). Owing to the wealth of available genome‐wide tools and resources (see above), these breeds can now be studied in detail for genetic makeup, signatures of selection and relatedness to other breeds. The number of publications in the field is growing almost exponentially and these include a few seminal studies encompassing a global collection of breeds (McCue *et al*. [2012](#age12857-bib-0164){ref-type="ref"}; Petersen *et al*. [2013a](#age12857-bib-0205){ref-type="ref"},[b](#age12857-bib-0206){ref-type="ref"}; Jagannathan *et al*. [2019](#age12857-bib-0109){ref-type="ref"}), and many studies specializing in a single breed or a group of related breeds, for example, the American Quarter Horse (Petersen *et al*. [2014a](#age12857-bib-0207){ref-type="ref"}; Avila *et al*. [2018](#age12857-bib-0007){ref-type="ref"}; Marchiori *et al*. [2019](#age12857-bib-0157){ref-type="ref"}; Pereira *et al*. [2019](#age12857-bib-0204){ref-type="ref"}), the Hanoverian and other German Warmblood breeds (Nanaei *et al*. [2019](#age12857-bib-0184){ref-type="ref"}; Nolte *et al*. [2019](#age12857-bib-0187){ref-type="ref"}), the Arabian and related Middle Eastern breeds (Almarzook *et al*. [2017](#age12857-bib-0003){ref-type="ref"}; Sadeghi *et al*. [2019](#age12857-bib-0229){ref-type="ref"}), and some native/primitive breeds such as Hucul and Konik (Gurgul *et al*. [2019](#age12857-bib-0092){ref-type="ref"}), Chinese native horses (Zhang *et al*. [2018](#age12857-bib-0302){ref-type="ref"}), Japanese native breeds (Tozaki *et al*. [2019](#age12857-bib-0269){ref-type="ref"}), the Yakutian Horse (Librado *et al*. [2015](#age12857-bib-0139){ref-type="ref"}) and Korean horses (Seong *et al*. [2019](#age12857-bib-0240){ref-type="ref"}). This is by no means an exhaustive list and it is even longer when including breeds that have recently been studied based on a genome‐wide collection of microsatellite markers, such as Estonian horse breeds (Sild *et al*. [2019](#age12857-bib-0247){ref-type="ref"}) or Konik (Szwaczkowski *et al*. [2016](#age12857-bib-0258){ref-type="ref"}).

Despite the large number of studies, the core findings are rather similar. Collectively, modern horse breeds are characterized by high inter‐breed and low intra‐breed genetic diversity (McCue *et al*. [2012](#age12857-bib-0164){ref-type="ref"}; Petersen *et al*. [2013a](#age12857-bib-0205){ref-type="ref"}). Genomes of modern horses show multiple regions with signatures of selective pressures on performance traits and phenotypes. Among these, the most prominent are the *MSTN* gene in ECA18 for muscle fibers in racing breeds (Petersen *et al*. [2013b](#age12857-bib-0206){ref-type="ref"}; Avila *et al*. [2018](#age12857-bib-0007){ref-type="ref"}), the *DMRT3* gene in ECA23 to perform alternative gaits in many breeds (Petersen *et al*. [2013b](#age12857-bib-0206){ref-type="ref"}), and a region in ECA11 for body size in draught breeds and Miniature Horses (Petersen *et al*. [2013b](#age12857-bib-0206){ref-type="ref"}). Clear signatures of selection are also found at known coat color loci. For example, the recessive chestnut coat color locus at *MC1R* is defined by a conserved approximately 750 kb haplotype across all breeds studied (McCue *et al*. [2012](#age12857-bib-0164){ref-type="ref"}) and robust signatures of selection at the *TBX3* locus in ECA8 are found in Konik horses, known to be selected for the dun color (Gurgul *et al*. [2019](#age12857-bib-0092){ref-type="ref"}). Finally, selective breeding for the desired traits in modern breeds has unwillingly introduced accumulation of deleterious mutations (Librado *et al*. [2016](#age12857-bib-0140){ref-type="ref"}, [2017](#age12857-bib-0141){ref-type="ref"}; Jagannathan *et al*. [2019](#age12857-bib-0109){ref-type="ref"}). For example, recent WGSs of 88 horses across 25 breeds identified heterozygotes for two potentially deleterious recessive alleles: a nonsense variant in the *PALB2* gene, which is essential for mesoderm development, and a nonsense variant in the *PLEKHM1* gene, necessary for osteoclast functions (Jagannathan *et al*. [2019](#age12857-bib-0109){ref-type="ref"}).

Investigating Mendelian traits {#age12857-sec-0015}
==============================

The investigation of Mendelian traits in the horse began in the early 1900s. Because of the relative ease of tracking simply inherited phenotypes across generations, some of the first Mendelian traits to be studied involved variations in pigmentation. In fact, Alfred Sturtevant, an undergraduate student working on mapping traits in *Drosophila* under Thomas Hunt Morgan, was among the first to publish on inheritance of coat color in harness horses (Sturtevant [1920](#age12857-bib-0255){ref-type="ref"}). However, it was almost 100 years later when the genetic mechanism proposed by Sturtevant for the chestnut coat color was identified at the molecular level (Table [2](#age12857-tbl-0002){ref-type="table"}). This and other variants identified in the early 2000s influencing pigmentation were discovered using candidate gene approaches. To date, 58 variants affecting pigmentation have been described, including 27 in the *KIT* gene that contribute to the dominant white phenotype. The identification of the majority of these pigmentation variants was made possible by the high quality of the horse reference genome sequence and available SNP array tools (Tables [2](#age12857-tbl-0002){ref-type="table"} and [S1](#age12857-sup-0001){ref-type="supplementary-material"} and described above). For example, the initial horse linkage map developed by the horse genomics community (Penedo *et al*. [2005](#age12857-bib-0202){ref-type="ref"}) allowed for the mapping of several pigmentation traits with pleiotropic effects, such as leopard complex spotting (Terry *et al*. [2004](#age12857-bib-0261){ref-type="ref"}) and gray depigmentation (Pielberg *et al*. [2005](#age12857-bib-0210){ref-type="ref"}). However, the discovery of causal variants was possible only through the availability of a reference genome that enabled both whole genome and RNA‐seq data analyses to uncover large structural variants (Rosengren Pielberg *et al*. [2008](#age12857-bib-0227){ref-type="ref"}; Bellone *et al*. [2013](#age12857-bib-0016){ref-type="ref"}).

The first genetic disorder to be identified at the molecular level in the horse was hyperkalemic periodic paralysis, reported in 1992. Much like the early work investigating pigmentation in the horse, this was discovered by a candidate gene approach. At the time the first draft of the horse genome sequence was complete, nearly 15 years later, only nine disease causing mutations had been discovered (Tables [3](#age12857-tbl-0003){ref-type="table"} and [S2](#age12857-sup-0002){ref-type="supplementary-material"}). In the last several years, there has been acceleration in the discovery of causal or highly associated variants for Mendelian traits, with 14 variants reported in the last four years. This acceleration in discovery is due to advances in genomic tools and resources. DNA testing for these Mendelian traits has enabled marker‐assisted selection to be utilized by horse breeders and in some cases is helping to assist in the clinical management of disease.

Genetics of complex traits {#age12857-sec-0016}
==========================

Traits considered complex are those which are not determined by one or a few genomic variants but rather by small contributions of many and perhaps hundreds of variants across the genome. These traits are generally lowly heritable, as the phenotypic outcome is determined not only by the underlying genetic variation but also by a significant impact of the environment (e.g. nutrition, training). The role of the environment complicates both the identification and understanding of the genetic components driving these phenotypes. That said, complex traits are of significance to the industry, both economically and for animal wellbeing and include measures of athletic performance, growth and body size, and disorders such as metabolic syndrome, laminitis, equine asthma or recurrent airway obstruction (RAO) and osteochondrosis (OC), among others. Given the availability of genome‐wide genotyping technologies, researchers have been working to piece together the role of genetics in these complex traits. What is known regarding the genetic basis of several of the most highly studied complex traits in horses is outlined below.

Size {#age12857-sec-0017}
----

Unlike many complex traits, the size of the horse is highly heritable with estimates for wither height ranging from 0.52 to 0.78 (Molina *et al*. [1999](#age12857-bib-0180){ref-type="ref"}; Zechner *et al*. [2001](#age12857-bib-0301){ref-type="ref"}; Suontama *et al*. [2009](#age12857-bib-0256){ref-type="ref"}; Signer‐Hasler *et al*. [2012](#age12857-bib-0245){ref-type="ref"}). Not surprisingly, positive genetic and phenotypic correlations are reported between wither height and other growth phenotypes such as body length, heart girth and cannon bone circumference (Molina *et al*. [1999](#age12857-bib-0180){ref-type="ref"}; Sadek *et al*. [2006](#age12857-bib-0230){ref-type="ref"}). Providing insight into the biology underlying size, Makvandi‐Nejad *et al*. ([2012](#age12857-bib-0155){ref-type="ref"}) employed the 50K SNP array to identify four loci that explained a majority of variation in size across‐breeds. The loci identified in this work include *LCORL/NCAPG*,*HMGA2*,*ZFAT* and *LASP1*, most of which have also been shown to play a role in size and growth phenotypes in other species (Snelling *et al*. [2010](#age12857-bib-0248){ref-type="ref"}; Weikard *et al*. [2010](#age12857-bib-0291){ref-type="ref"}; Lindholm‐Perry *et al*. [2013](#age12857-bib-0143){ref-type="ref"}; Saatchi *et al*. [2014](#age12857-bib-0228){ref-type="ref"}). Additional work has supported the association of *LCORL/NCAPG* (Signer‐Hasler *et al*. [2012](#age12857-bib-0245){ref-type="ref"}; Tetens *et al*. [2013](#age12857-bib-0262){ref-type="ref"}; Staiger *et al*. [2016a](#age12857-bib-0250){ref-type="ref"}; Tozaki *et al*. [2017](#age12857-bib-0268){ref-type="ref"}), *ZFAT* (Signer‐Hasler *et al*. [2012](#age12857-bib-0245){ref-type="ref"}; Tozaki *et al*. [2017](#age12857-bib-0268){ref-type="ref"}), and *HMGA2* (Frischknecht *et al*. [2015](#age12857-bib-0075){ref-type="ref"}) with height in various other populations. Whereas the means by which these loci act to alter growth traits is not fully understood, a missense mutation in *HMGA2* was reported to alter DNA binding, which was attributed to reduced size in ponies (Frischknecht *et al*. [2015](#age12857-bib-0075){ref-type="ref"}) and was also recently correlated with metabolic syndrome in Welsh ponies (Norton *et al*. [2019a](#age12857-bib-0188){ref-type="ref"}). Functionally, variation of *LCORL* was shown to alter its expression, which may explain its role in determining an individual\'s size (Metzger *et al*. [2013](#age12857-bib-0170){ref-type="ref"}). Interestingly, *LCORL* has also been associated with other complex disorders, including recurrent laryngeal neuropathy (Boyko *et al*. [2014](#age12857-bib-0027){ref-type="ref"}) and OC (Corbin *et al*. [2012](#age12857-bib-0048){ref-type="ref"}), serving as another example of the pleiotropic effects of loci involved in complex traits. As height has been associated with both OC and recurrent laryngeal neuropathy (Brakenhoff *et al*. [2006](#age12857-bib-0029){ref-type="ref"}; McGivney *et al*. [2019](#age12857-bib-0165){ref-type="ref"}), these associations are biologically relevant. The power of high‐density genome‐wide genotyping arrays has also enabled the identification of loci with more minor effects than those found by Makvandi‐Nejad *et al*. ([2012](#age12857-bib-0155){ref-type="ref"}) or which may be breed specific (Meira *et al*. [2014b](#age12857-bib-0167){ref-type="ref"}; Frischknecht *et al*. [2016](#age12857-bib-0076){ref-type="ref"}; Metzger *et al*. [2018](#age12857-bib-0174){ref-type="ref"}). It is important that height is treated distinctly from dwarfism, which is simply inherited in several populations including the Miniature Horse (Metzger *et al*. [2017](#age12857-bib-0173){ref-type="ref"}; Eberth *et al*. [2018](#age12857-bib-0062){ref-type="ref"}) and Friesian (Leegwater *et al*. [2016](#age12857-bib-0133){ref-type="ref"}; Table [3](#age12857-tbl-0003){ref-type="table"}).

Athletic performance {#age12857-sec-0018}
--------------------

The athletic ability of a horse, whether it be jumping, racing, cutting or pulling, is clearly complex, depending upon efficient metabolic and musculoskeletal properties as well as intricate interactions and the influence of training and husbandry. Particularly in Thoroughbreds, the genetics of racing performance has been of long‐standing interest. Prior to the availability of genotyping technologies, pedigree and performance data were used to examine the genetic components of phenotypic variance for Thoroughbred, Standardbred and sport horse performance (Hintz & Vanvleck [1978](#age12857-bib-0102){ref-type="ref"}; Ojala *et al*. [1987](#age12857-bib-0192){ref-type="ref"}; Tavernier [1990](#age12857-bib-0260){ref-type="ref"}; Árnason [2001](#age12857-bib-0006){ref-type="ref"}; Ricard & Chanu [2001](#age12857-bib-0221){ref-type="ref"}; Langlois & Blouin [2004](#age12857-bib-0127){ref-type="ref"}, [2007](#age12857-bib-0128){ref-type="ref"}). Heritability estimates for racing in the Thoroughbred range greatly from nearly zero to upwards of 0.75, depending upon the specific phenotype measured (e.g. race time, race length or race winnings) and the model assumed (O\'Ferrall & Cunningham [1974](#age12857-bib-0190){ref-type="ref"}; Gaffney & Cunningham [1988](#age12857-bib-0079){ref-type="ref"}; Williamson & Beilharz [1996](#age12857-bib-0294){ref-type="ref"}; Thiruvenkadan *et al*. [2009a](#age12857-bib-0264){ref-type="ref"}). As genotyping methodologies became available, regions implicated in racing performance have been identified using candidate gene (Gu *et al*. [2010](#age12857-bib-0091){ref-type="ref"}; Hill *et al*. [2010a](#age12857-bib-0099){ref-type="ref"}) and genome‐wide association analyses (Binns *et al*. [2010](#age12857-bib-0019){ref-type="ref"}; Hill *et al*. [2010b](#age12857-bib-0100){ref-type="ref"}; Tozaki *et al*. [2010](#age12857-bib-0267){ref-type="ref"}; Shin *et al*. [2015](#age12857-bib-0244){ref-type="ref"}) and transcriptome analyses (Park *et al*. [2014](#age12857-bib-0200){ref-type="ref"}), and through the identification of selective sweeps in racing populations (Moon *et al*. [2015](#age12857-bib-0181){ref-type="ref"}). Genes implicated include *COX4I2* (Gu *et al*. [2010](#age12857-bib-0091){ref-type="ref"}) and *PDK4* (Hill *et al*. [2010a](#age12857-bib-0099){ref-type="ref"}), both involved in cellular respiration. Although these studies have uncovered evidence of genetic factors involved in the racing performance of Thoroughbreds, a single locus, *MSTN*, has been repeatedly associated with racing performance (Binns *et al*. [2010](#age12857-bib-0019){ref-type="ref"}; Tozaki *et al*. [2010](#age12857-bib-0267){ref-type="ref"}). In 2010, an intronic variant of *MSTN* was noted to be predictive of a horse\'s best racing distance (Hill *et al*. [2010b](#age12857-bib-0100){ref-type="ref"}); the use of a genetic test for this variant has been adopted as a means to tailor training programs or choose matings. Since the first publication of this variant, several lines of evidence have supported the role of a SINE insertion in the promoter of *MSTN*, in high linkage disequilibrium with the intronic SNP in the Thoroughbred breed, as the functional variant (Petersen *et al*. [2014b](#age12857-bib-0208){ref-type="ref"}; Santagostino *et al*. [2015](#age12857-bib-0231){ref-type="ref"}; Rooney *et al*. [2018](#age12857-bib-0226){ref-type="ref"}).

Outside of the Thoroughbred, the *MSTN* variant predictive of better suitability as a sprinter is highly frequent in the Quarter Horse and associated with a higher proportion of fast‐twitch muscle fibers (Petersen *et al*. [2013b](#age12857-bib-0206){ref-type="ref"}, [2014b](#age12857-bib-0208){ref-type="ref"}). Additional studies in the racing Quarter Horse have identified other loci associated with racing performance; as a result of these works, genes involved in muscle contractility, skeletal development and neurologic function have been suggested to be associated with sprinting (Meira *et al*. [2014a](#age12857-bib-0166){ref-type="ref"},[c](#age12857-bib-0168){ref-type="ref"}; Beltran *et al*. [2015](#age12857-bib-0018){ref-type="ref"}). In some cases, variants for racing speed are common across breeds (Shin *et al*. [2015](#age12857-bib-0244){ref-type="ref"}; Pereira *et al*. [2016](#age12857-bib-0203){ref-type="ref"}), fitting a hypothesis that these horses shared selective pressures for superior metabolic and musculoskeletal traits. Efforts to understand the genetic components of variation in harness racing horses suggest that their heritability is low to moderate (reviewed in Thiruvenkadan *et al*. [2009b](#age12857-bib-0265){ref-type="ref"}). In the harness racing populations, similar to the role of *MSTN* in the Thoroughbreds, a single variant was reported to impact performance to the extent that the variant is nearly fixed in trotting breeds (Promerova *et al*. [2014](#age12857-bib-0213){ref-type="ref"}). The gene implicated, *DMRT3*, alters motor coordination and stride length (Andersson *et al*. [2012](#age12857-bib-0004){ref-type="ref"}); horses homozygous for the variant perform at a higher level than those heterozygous or wt (Jaderkvist *et al*. [2014](#age12857-bib-0108){ref-type="ref"}; Jaderkvist Fegraeus *et al*. [2015](#age12857-bib-0107){ref-type="ref"}). Interestingly, this variant was identified not in a study of racing performance but in a study of another complex trait in the horse---the ability to perform an alternative gait (Andersson *et al*. [2012](#age12857-bib-0004){ref-type="ref"}), again demonstrating the interplay among physiological pathways. As an aside, whereas the *DMRT3* variant is deemed necessary for 'gaitedness', the basis of variations in gait is yet to be understood (Patterson *et al*. [2015](#age12857-bib-0201){ref-type="ref"}; Staiger *et al*. [2016a](#age12857-bib-0250){ref-type="ref"}; Fegraeus *et al*. [2017](#age12857-bib-0065){ref-type="ref"}; Fonseca *et al*. [2017](#age12857-bib-0073){ref-type="ref"}).

Requiring a different type of athleticism, endurance racing studied in Arabian horses identified five QTL, including genes hypothesized to be involved in neuronal and cardiac function (Ricard *et al*. [2017](#age12857-bib-0223){ref-type="ref"}). As in complex traits, how the regulation of these genes or variants within them may enhance performance is an area of study. The differentially expression of microRNAs prior to and after endurance exercise is probably one means by which gene regulation is altered to allow horses to endure and excel at this type of performance (Mach *et al*. [2016](#age12857-bib-0153){ref-type="ref"}).

Sport horses require yet another type of athleticism and the heritability and genetics of show jumping and dressage have been studied in several European populations. Heritability estimates, calculated for the longevity (years) of performance, have been similar across studies ranging from 0.07 to 0.18 (Ricard & FournetHanocq [1997](#age12857-bib-0222){ref-type="ref"}; Braam *et al*. [2011](#age12857-bib-0028){ref-type="ref"}; Seiero *et al*. [2016](#age12857-bib-0239){ref-type="ref"}; Ricard *et al*. [2017](#age12857-bib-0223){ref-type="ref"}). Heritability estimates for show jumping range from 0.11 (Sole *et al*. [2017](#age12857-bib-0249){ref-type="ref"}) to 0.61 (Stock & Distl [2007](#age12857-bib-0253){ref-type="ref"}), and in most cases are greater than estimates for dressage in the same population (Viklund *et al*. [2010](#age12857-bib-0278){ref-type="ref"}; Braam *et al*. [2011](#age12857-bib-0028){ref-type="ref"}), although this is not the case in the Swedish Warmblood studied by Wallin *et al*. ([2003](#age12857-bib-0283){ref-type="ref"}).

Finally, the use of the Illumina Equine50 SNP array to investigate the biology underlying the success of jumpers revealed a QTL explaining 0.7% of the phenotypic variance in French Warmbloods in a region including the candidate gene *RYR2* (Brard & Ricard [2015](#age12857-bib-0031){ref-type="ref"}). In the Hanoverian, a GWAS using the same genotyping platform identified six QTL including genes predicted to function in muscle structure and metabolism (Schroder *et al*. [2012](#age12857-bib-0236){ref-type="ref"}).

Osteochondrosis {#age12857-sec-0019}
---------------

Osteochondrosis is a dysregulation of endochondral ossification of cartilage at the articular/epiphyseal complex most commonly occurring at the fetlock, hock and stifle joints (Jeffcott [1996](#age12857-bib-0112){ref-type="ref"}). As a result, the cartilage becomes thickened and/or is retained, interfering with the normal function of the joint (Jeffcott [1996](#age12857-bib-0112){ref-type="ref"}). The prevalence of OC varies by breed with relatively low incidence (\~7%) in Thoroughbreds (Kane *et al*. [2003](#age12857-bib-0117){ref-type="ref"}) and moderate frequency (\~30%) in Danish Warmbloods (van Grevenhof *et al*. [2009](#age12857-bib-0090){ref-type="ref"}), and with estimates of as many as 50% of Standardbred and German coldblooded horses (Wittwer *et al*. [2006](#age12857-bib-0296){ref-type="ref"}; Lykkjen *et al*. [2012](#age12857-bib-0152){ref-type="ref"}) being affected. Although it can be quite common, the heritability of OC is low to moderate (reviewed in Distl [2013](#age12857-bib-0057){ref-type="ref"}; Naccache *et al*. [2018](#age12857-bib-0183){ref-type="ref"}; McCoy *et al*. [2019](#age12857-bib-0163){ref-type="ref"}), with a variety of environmental factors identified as having a significant role in its occurrence (Lepeule *et al*. [2009](#age12857-bib-0135){ref-type="ref"}, [2013](#age12857-bib-0136){ref-type="ref"}; Vander Heyden *et al*. [2013](#age12857-bib-0276){ref-type="ref"}). Incidence has been positively correlated with size (Stock *et al*. [2005](#age12857-bib-0254){ref-type="ref"}) and *LCORL*, itself associated with the size of a horse (described above), has been noted as a risk factor for OC and associated with incidence in GWAS (Teyssedre *et al*. [2012](#age12857-bib-0263){ref-type="ref"}; Orr *et al*. [2013](#age12857-bib-0196){ref-type="ref"}; Naccache *et al*. [2018](#age12857-bib-0183){ref-type="ref"}). In Thoroughbreds, a QTL also on ECA3, although over 20 Mb distant from *LCORL*, was estimated to explain over 30% of the genetic variation (Corbin *et al*. [2012](#age12857-bib-0048){ref-type="ref"}). Several research groups have been working to identify genetic risk factors for OC. The complexity as well as hypothesized population‐specific risk factors are evident in the many loci associated using genome‐wide SNP assays, many of which do not overlap between populations (Dierks *et al*. [2007](#age12857-bib-0053){ref-type="ref"}, [2010](#age12857-bib-0054){ref-type="ref"}; Wittwer *et al*. [2007](#age12857-bib-0297){ref-type="ref"}; Lampe *et al*. [2009a](#age12857-bib-0124){ref-type="ref"},[b](#age12857-bib-0125){ref-type="ref"}; Lykkjen *et al*. [2010](#age12857-bib-0151){ref-type="ref"}; Corbin *et al*. [2012](#age12857-bib-0048){ref-type="ref"}; Teyssedre *et al*. [2012](#age12857-bib-0263){ref-type="ref"}; Orr *et al*. [2013](#age12857-bib-0196){ref-type="ref"}; McCoy *et al*. [2016](#age12857-bib-0162){ref-type="ref"}; Lewczuk *et al*. [2017](#age12857-bib-0137){ref-type="ref"}; Table [4](#age12857-tbl-0004){ref-type="table"}).

###### 

Complex equine diseases and traits with ongoing genetic studies.

+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Disease/trait (reference)                                                                                                                                                                                                                                                                                                                                  | Breed                                                 | Type of genetic study            | Genomic region(s) identified                                                                                                                                                   |
+============================================================================================================================================================================================================================================================================================================================================================+=======================================================+==================================+================================================================================================================================================================================+
| Atrial fibrillation (Physick‐Sheard *et al*. [2014](#age12857-bib-0209){ref-type="ref"}; Kraus *et al*. [2017](#age12857-bib-0121){ref-type="ref"})                                                                                                                                                                                                        | Standardbred                                          | Heritability only                | Probably polygenic; no region identified to date                                                                                                                               |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Body size (e.g. Makvandi‐Nejad *et al*. [2012](#age12857-bib-0155){ref-type="ref"})                                                                                                                                                                                                                                                                        | Multiple                                              | GWAS                             | Loci on ECA3, 6, 9 and 11                                                                                                                                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Bone fracture (Blott & Vaudin [2013](#age12857-bib-0021){ref-type="ref"}; Blott *et al*. [2014](#age12857-bib-0022){ref-type="ref"})                                                                                                                                                                                                                       | Thoroughbred                                          | GWAS                             | ECA18                                                                                                                                                                          |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Brachygnathia (Signer‐Hasler *et al*. [2014](#age12857-bib-0246){ref-type="ref"})                                                                                                                                                                                                                                                                          | Franches‐Montagnes                                    | GWAS                             | ECA13                                                                                                                                                                          |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Chronic progressive lymphedema (De Keyser *et al*. [2014](#age12857-bib-0049){ref-type="ref"}),[a](#age12857-note-0006){ref-type="fn"}                                                                                                                                                                                                                     | Draft breeds                                          | Candidate gene approach          | Continuing to pursue sequencing *ELN*                                                                                                                                          |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Common variable immunodeficiency [b](#age12857-note-0007){ref-type="fn"}                                                                                                                                                                                                                                                                                   | Various                                               | Epigenetic investigation         | RNA‐seq and Methyl‐Seq of *E2A* and *PAX5*                                                                                                                                     |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Corneal stromal loss (Lassaline‐Utter *et al*. [2014](#age12857-bib-0130){ref-type="ref"}; Alberi *et al*. [2018](#age12857-bib-0002){ref-type="ref"})                                                                                                                                                                                                     | Friesian                                              | Heritability only/candidate gene | Likely heritable; excluded *BGN* variants                                                                                                                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cribbing (crib‐biting) (Hemmann *et al*. [2014](#age12857-bib-0094){ref-type="ref"})                                                                                                                                                                                                                                                                       | Multiple                                              | Candidate gene                   | Excluded subset of stereotypic genes                                                                                                                                           |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Cryptorchidism[a](#age12857-note-0006){ref-type="fn"}                                                                                                                                                                                                                                                                                                      | Icelandic                                             | Heritability only                | Likely to be heritable                                                                                                                                                         |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Degenerative joint disease (Welsh *et al*. [2013](#age12857-bib-0292){ref-type="ref"})                                                                                                                                                                                                                                                                     | Thoroughbred                                          | Heritability only                | Small to moderate heritability identified                                                                                                                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Guttural pouch tympany (Metzger *et al*. [2012](#age12857-bib-0169){ref-type="ref"})                                                                                                                                                                                                                                                                       | Arabians and German Warmbloods                        | GWAS                             | ECA15 (Arabians) and ECA3 (German Warmbloods)                                                                                                                                  |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Insect bite hypersensitivity (Schurink *et al*. [2012](#age12857-bib-0238){ref-type="ref"}; Velie *et al*. [2016](#age12857-bib-0277){ref-type="ref"})                                                                                                                                                                                                     | Icelandic, Shetland and Exmoor                        | GWAS                             | ECA7, 9, 10 and 17                                                                                                                                                             |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ECA8 (Exmoor)                                                                                                                                                                  |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Recurrent laryngeal neuropathy (Dupuis *et al*. [2011](#age12857-bib-0061){ref-type="ref"}; Boyko *et al*. [2014](#age12857-bib-0027){ref-type="ref"})                                                                                                                                                                                                     | Thoroughbred, Warmblood, Trotter and Draft            | GWAS                             | ECA3 (height locus; Thoroughbred)                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ,                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ECA21 and 31 (Multiple breeds)                                                                                                                                                 |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Metabolic syndrome (Lewis *et al*. [2017](#age12857-bib-0138){ref-type="ref"}; Norton *et al*. [2019b](#age12857-bib-0189){ref-type="ref"},[a](#age12857-bib-0188){ref-type="ref"}) [a](#age12857-note-0006){ref-type="fn"}                                                                                                                                | Welsh pony, Arabian, Morgan                           | GWAS                             | ECA6 (Welsh pony)                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ,                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ECA14 (Arabian)                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ,                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | multiple regions (Morgan)                                                                                                                                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Navicular disease (Diesterbeck *et al*. [2007](#age12857-bib-0055){ref-type="ref"}; Lopes *et al*. [2009](#age12857-bib-0147){ref-type="ref"}, [2010](#age12857-bib-0148){ref-type="ref"})                                                                                                                                                                 | Warmbloods                                            | GWAS                             | ECA2 and ECA10                                                                                                                                                                 |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Neuroaxonal dystrophy/equine degenerative myeloencephalopathy (Finno *et al*. [2013](#age12857-bib-0070){ref-type="ref"}, [2014](#age12857-bib-0071){ref-type="ref"})                                                                                                                                                                                      | Quarter Horse                                         | GWAS                             | ECA8 region exclusion, exclusion of *TTPA* candidate gene                                                                                                                      |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Osteochondrosis/osteochondrosis dissecans (Dierks *et al*. [2007](#age12857-bib-0053){ref-type="ref"}; Lampe *et al*. [2009a](#age12857-bib-0124){ref-type="ref"},[b](#age12857-bib-0125){ref-type="ref"},[c](#age12857-bib-0126){ref-type="ref"}; Sevane *et al*. [2016](#age12857-bib-0241){ref-type="ref"}, [2017](#age12857-bib-0242){ref-type="ref"}) | Warmbloods, Trotters, Standardbreds, Spanish Purebred | GWAS                             | ECA2, 4, 5, 16, 18 (Warmblood)                                                                                                                                                 |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ,                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ECA10, 14, 21 (Standardbred)                                                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ,                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | candidate gene analysis (Spanish Purebred)                                                                                                                                     |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Polysaccharide storage myopathy, type II[a](#age12857-note-0006){ref-type="fn"}                                                                                                                                                                                                                                                                            | Quarter Horses                                        | GWAS                             | ECA18                                                                                                                                                                          |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Recurrent airway obstruction (Swinburne *et al*. [2009](#age12857-bib-0257){ref-type="ref"}; Schnider *et al*. [2017](#age12857-bib-0233){ref-type="ref"}; Mason *et al*. [2018](#age12857-bib-0159){ref-type="ref"})                                                                                                                                      | Warmblood                                             | GWAS                             | ECA 11, 13, 15 (Warmblood)                                                                                                                                                     |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Recurrent exertional rhabdomyolysis (Fritz *et al*. [2012](#age12857-bib-0077){ref-type="ref"})                                                                                                                                                                                                                                                            | Thoroughbred, Standardbred                            | GWAS                             | ECA11, 16, 30 (Thoroughbred)                                                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ,                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ECA10, 11 (Standardbred)                                                                                                                                                       |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Recurrent uveitis (Kulbrock *et al*. [2013](#age12857-bib-0123){ref-type="ref"}; Fritz *et al*. [2014](#age12857-bib-0078){ref-type="ref"})                                                                                                                                                                                                                | Appaloosa, German Warmblood                           | Candidate gene/GWAS              | ECA1, 20 (Appaloosa)                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ,                                                                                                                                                                              |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  | ECA18, 20 (German Warmblood)                                                                                                                                                   |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Sarcoid (Christen *et al*. [2013](#age12857-bib-0042){ref-type="ref"}; Staiger *et al*. [2016b](#age12857-bib-0251){ref-type="ref"})                                                                                                                                                                                                                       | Franches‐Montagnes                                    | GWAS                             | ECA20, 22 (QH, TB)                                                                                                                                                             |
|                                                                                                                                                                                                                                                                                                                                                            |                                                       |                                  |                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                            | , Quarter Horse, Thoroughbred                         |                                  |                                                                                                                                                                                |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Stallion subfertility owing to impaired acrosome reaction (Raudsepp *et al*. [2012](#age12857-bib-0218){ref-type="ref"})                                                                                                                                                                                                                                   | Thoroughbred                                          | Susceptibility gene              | ECA13: *FKBP6*                                                                                                                                                                 |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Stallion fertility (Schrimpf *et al*. [2015](#age12857-bib-0234){ref-type="ref"})                                                                                                                                                                                                                                                                          | Hanoverian                                            | GWAS                             | ECA13: *FKBP6*                                                                                                                                                                 |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Stallion fertility (Schrimpf *et al*. [2016](#age12857-bib-0235){ref-type="ref"})                                                                                                                                                                                                                                                                          | 19 European breeds                                    | GWAS                             | High‐impact variants in *CFTR* (ECA4), *OVGP1* (ECA5), *FBXO43* (ECA9), *TSSK6* (ECA21), *PKD1* (ECA13), *FOXP1* (ECA16), *TCP11* (ECA20), *SPATA31E1* (n/a), *NOTCH1* (ECA25) |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Swayback (lordosis) (Cook *et al*. [2010](#age12857-bib-0047){ref-type="ref"})                                                                                                                                                                                                                                                                             | Saddlebred                                            | GWAS                             | ECA20                                                                                                                                                                          |
+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------------------------+----------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

ECA, *Equus caballus* chromosome; GWA, genome‐wide association.
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Functional studies show differential expression of the *MMP‐13* gene, encoding for a matrix metallopeptidase, in the cartilage of horses with OC compared with controls (Mirams *et al*. [2009](#age12857-bib-0178){ref-type="ref"}; Riddick *et al*. [2012](#age12857-bib-0224){ref-type="ref"}), consistent with hypothesized dysfunction in cartilage maturation and endochondral ossification. Candidate gene expression studies also suggest that chondrocyte maturation and catabolism are altered through dysregulated Wnt signaling (Kinsley *et al*. [2015](#age12857-bib-0119){ref-type="ref"}). Finally, Mirams *et al*. ([2016](#age12857-bib-0179){ref-type="ref"}) used subtractive hybridization of the transcriptome from cartilage of affected and unaffected foals resulting in a hypothesized etiology that involves cartilage retention in subchondral bone. In addition to protein coding transcripts, differentially expressed miRNAs have been identified and may play a role in alteration of gene expression associated with OC (Desjardin *et al*. [2014](#age12857-bib-0051){ref-type="ref"}).

Equine metabolic syndrome and laminitis {#age12857-sec-0020}
---------------------------------------

Horses affected by equine metabolic syndrome (EMS) present with insulin resistance and obesity and/or regional adiposity; additionally, hypertriglyceridemia, elevated leptin and hypertension may occur (Frank *et al*. [2010](#age12857-bib-0074){ref-type="ref"}). Horses with EMS have an increased risk of laminitis or the disruption of the attachment between the distal phalanx (coffin bone) and inner hoof wall, leading to the coffin bone being rotated downward into the sole of the hoof. The incidence of EMS and associated laminitis is greatest in ponies and obese horses (Treiber *et al*. [2006](#age12857-bib-0270){ref-type="ref"}; Bailey *et al*. [2008](#age12857-bib-0009){ref-type="ref"}). Not all cases of laminitis, however, are attributed to EMS as it can occur in conjunction with other wellbeing issues such as colic, abdominal or reproductive infection, or excessive concussion on hard surfaces (Hood [1999](#age12857-bib-0103){ref-type="ref"}).

SNP‐based heritability estimates for traits associated with EMS (e.g. circulating insulin, glucose, ACTH, leptin) have been reported to be quite high (Norton *et al*. [2019b](#age12857-bib-0189){ref-type="ref"}). Genetic factors contributing to risk are also supported by varied rates of prevalence among breeds and variation in insulin responsiveness by breed (Treiber *et al*. [2006](#age12857-bib-0270){ref-type="ref"}; Bailey *et al*. [2008](#age12857-bib-0009){ref-type="ref"}; Bamford *et al*. [2014](#age12857-bib-0011){ref-type="ref"}). In a study of pedigreed ponies, Treiber *et al*. ([2006](#age12857-bib-0270){ref-type="ref"}) proposed that one or a few major dominant genes contribute to predisposition to laminitis.

Changes in gene expression related to the onset of laminitis have been studied as a possible means of both understanding the progression of the condition and identifying biomarkers to detect a possible bout prior to the onset of clinical symptoms. With a hypothesized inflammatory component, Tadros *et al*. ([2013](#age12857-bib-0259){ref-type="ref"}) found that circulating cytokine expression of IL‐1B, IL‐8 and IL‐10 was elevated several hours prior to the detectable onset of laminitis. A similar inflammatory response has been identified in the laminar tissue itself in horses induced to develop laminitis compared with healthy controls (Belknap *et al*. [2007](#age12857-bib-0015){ref-type="ref"}; Loftus *et al*. [2007](#age12857-bib-0146){ref-type="ref"}; Leise *et al*. [2010](#age12857-bib-0134){ref-type="ref"}). These studies show a systemic inflammatory response associated with laminitis. However, whereas these studies help identify pathways involved in disease progression, they fail to answer questions of genetic risk.

Toward the goal of understanding genetic risk factors for disease, Lewis *et al*. ([2017](#age12857-bib-0138){ref-type="ref"}) identified a single candidate gene, *FAM174A*, in Arabian horses associated with laminitis and correlated with an increased insulin‐to‐glucose ratio. However, a more complete understanding of the genetic risk factors for EMS remains elusive. Finally, the influence of the microbiome on the development of EMS and the associated laminitis is a recent area of study. Characterization of the hindgut microbiome revealed differences in microbial composition in horses with chronic (Steelman *et al*. [2012](#age12857-bib-0252){ref-type="ref"}) and induced (Milinovich *et al*. [2006](#age12857-bib-0177){ref-type="ref"}) laminitis, as well as in horses with EMS (Elzinga *et al*. [2016](#age12857-bib-0063){ref-type="ref"}) compared with healthy controls. The composition of the microbiome itself has been suggested to be heritable (Blekhman *et al*. [2015](#age12857-bib-0020){ref-type="ref"}; Goodrich *et al*. [2016](#age12857-bib-0088){ref-type="ref"}), associated with genes involved in metabolism and immunity; these data connect host genetics to yet another means by which risk for EMS and/or laminitis may be amplified.

Equine asthma or RAO {#age12857-sec-0021}
--------------------

Equine asthma, also known as RAO or heaves, is a chronic disease of the lower airway, particularly problematic in environments where air flow is limited and in which bedding or hay has high levels of dust or other respiratory irritants (reviewed in Woods *et al*. [1993](#age12857-bib-0298){ref-type="ref"}; Ramseyer *et al*. [2007](#age12857-bib-0216){ref-type="ref"}; Pirie [2014](#age12857-bib-0212){ref-type="ref"}). The prevalence of RAO is estimated to be 14% in a sample of British horses (Hotchkiss *et al*. [2007](#age12857-bib-0104){ref-type="ref"}) and 10% in Swiss Warmbloods (Ramseyer *et al*. [2007](#age12857-bib-0216){ref-type="ref"}). Often compared with asthma in humans, affected individuals have difficulty breathing, neutrophil and mucus accumulation in the airway, cholinergic bronchospasm and coughing, and are especially sensitive to inhaled allergens (Robinson *et al*. [1996](#age12857-bib-0225){ref-type="ref"}; Gerber *et al*. [2004](#age12857-bib-0082){ref-type="ref"}). Whereas symptoms can be mediated by removing the horse from the problematic environment (Vandenput *et al*. [1998a](#age12857-bib-0274){ref-type="ref"},[b](#age12857-bib-0275){ref-type="ref"}), observations of increased risk in foals with affected parents, or foals of particular families (Marti *et al*. [1991](#age12857-bib-0158){ref-type="ref"}; Ramseyer *et al*. [2007](#age12857-bib-0216){ref-type="ref"}), have suggested a heritable component to its etiology.

Before genomic tools, a hypothesis derived from the clinical accumulation of mucus in RAO‐affected horses led to the investigation of mucin gene variation as a possible risk factor. As a result, the equine ortholog of *MUC5AC* was identified as being upregulated in affected horses (Gerber *et al*. [2003](#age12857-bib-0081){ref-type="ref"}). A candidate gene study also found an isoform of *MYH11* to be overexpressed in affected horses (Boivin *et al*. [2014](#age12857-bib-0024){ref-type="ref"}). The origin of the *MYH11* isoform identified in Boivin *et al*. ([2014](#age12857-bib-0024){ref-type="ref"}) has been associated with alternative regulatory mechanisms (Issouf *et al*. [2018](#age12857-bib-0105){ref-type="ref"}), providing an example of how variable genome regulation contributes to important phenotypes associated with animal health and wellbeing.

In perhaps the most highly studied populations of horses, and prior to the genome assembly, the candidate gene *IL4R* was investigated in two half‐sibling families of Warmbloods using microsatellite genotyping (Jost *et al*. [2007](#age12857-bib-0114){ref-type="ref"}). In one family, a significant association with RAO was found with a haplotype in ECA13 near the cytokine *IL4R,* and a recessive mode of inheritance was suggested. However, this association was not consistent in the other family, where an association with RAO was identified in ECA15 with a predicted dominant mode of inheritance. In a GWAS of these families using microsatellites, QTL were identified on ECA13, and whereas no association was found with the positional candidate gene *ITGAX*,*IL4R* was noted to be proximal to the hit (Swinburne *et al*. [2009](#age12857-bib-0257){ref-type="ref"}). In Shakhsi‐Niaei *et al*. ([2012](#age12857-bib-0243){ref-type="ref"}) the same research group used SNP50 to fine‐map the region, which resulted in the identification of a signal on ECA13 in both the family from which the original QTL was identified and a group of unrelated horses; however, the result was not statistically significant and no clear casual mutation or genes were identified. Chromosome 13 was again the strongest region of association in a GWAS repeated on these horses with the high‐density Affymetrix SNP array after it became available (Schnider *et al*. [2017](#age12857-bib-0233){ref-type="ref"}); the authors note positional candidate gene, *TXNDC11*, from those analyses.

Sequencing of *IL4R* and expression from bronchoalveolar lavage fluid identified increased expression in horses from which the association was derived but not in other horse families (Klukowska‐Rotzler *et al*. [2012](#age12857-bib-0120){ref-type="ref"}), further supporting its hypothesized role in RAO in this population. Additional follow‐up studies included quantitative PCR of candidate genes (Lanz *et al*. [2013](#age12857-bib-0129){ref-type="ref"}) and RNA‐seq (Pacholewska *et al*. [2015](#age12857-bib-0199){ref-type="ref"}) of peripheral blood mononuclear cells (PBMCs) derived from RAO‐affected and control horses that were stimulated with irritants such as hay dust or lipopolysaccharide. The role of *IL4R* in the population in which the QTL was identified was supported whereas other data continued to support different mechanisms of disease between the two families (Lanz *et al*. [2013](#age12857-bib-0129){ref-type="ref"}). RNA‐seq of horses from the sample families found *CXCL13* to be upregulated along with cell cycle regulatory transcripts such as *CDC20*, and genes involved in immune function and development (Pacholewska *et al*. [2015](#age12857-bib-0199){ref-type="ref"}). Finally, Mason *et al*. ([2018](#age12857-bib-0159){ref-type="ref"}) conducted expression QTL studies of experimentally treated PBMCs from horses with prior RAO and healthy controls; whereas the studies supported prior SNP associations in these families, the identification of functional risk markers remains elusive.

Lastly, considering the possible impact of variations other than nucleotide substitutions, genomic copy number variants were analyzed using a tiling array to compare variants of RAO with control horses (Ghosh *et al*. [2014](#age12857-bib-0083){ref-type="ref"}). Over 700 CNVs were identified across samples with the RAO horses found to have, on average, more CNVs than the controls. Although no significant associations were identified, *NME7*, involved in ciliary function of the lung, had a suggestive (*P *=* *0.06) association with the RAO phenotype, warranting further investigation (Ghosh *et al*. [2016](#age12857-bib-0084){ref-type="ref"}).

Reproduction {#age12857-sec-0022}
------------

Compared with other complex traits, the genomics of equine reproduction has been given relatively less attention, even though reproductive performance is of high economic importance for purebred horses and vital for survival in feral populations (Raudsepp *et al*. [2013](#age12857-bib-0219){ref-type="ref"}; Metzger *et al*. [2015](#age12857-bib-0172){ref-type="ref"}). Only a few candidate loci or genomic regions have been associated with various fertility parameters and phenotypes (Raudsepp *et al*. [2013](#age12857-bib-0219){ref-type="ref"}). Among these, the *FKBP6* gene is of particular interest because of contrasting associations: in Thoroughbreds it is associated with subfertility owing to impaired acrosome reaction (Raudsepp *et al*. [2012](#age12857-bib-0218){ref-type="ref"}), but in Hanoverians it is associated with improved conception rates (Schrimpf *et al*. [2015](#age12857-bib-0234){ref-type="ref"}). Like for other complex traits, genome‐wide SNP‐ or WGS‐based analyses are expected to also make a difference in fertility research. A good example is a recent whole‐genome screening that revealed high‐impact variants in nine putative male fertility genes (Schrimpf *et al*. [2016](#age12857-bib-0235){ref-type="ref"}; Table [4](#age12857-tbl-0004){ref-type="table"}).

On a different note, breeding animals are typically selected on the basis of their pedigrees, athletic performance and appearance, but not for their reproductive potential. This suggests that there are no strong signatures of selection for reproductive performance. Surprisingly, this is not true as shown by a whole‐genome analysis of runs of homozygosity in six diverse breeds, including commercial breeds such as Hanoverian and Thoroughbred, and native breeds such as Sorraia (Metzger *et al*. [2015](#age12857-bib-0172){ref-type="ref"}). The findings suggest a significant artificial as well as natural positive selection on reproduction performance in all types of horse populations.

Horse as a large animal model for humans {#age12857-sec-0023}
========================================

Unlike rats or mice, horses are large and expensive animals with long generation intervals, and therefore are not typical model species for studying human disease and physiology. However, some equine conditions, such as obesity, respiratory disease, orthopedic disease, equine recurrent uveitis and certain cancers translate into similar human conditions better than those from classical model species. For example, because of unique similarities between human and horse insulin resistance response to overfeeding, EMS has the potential to serve as a model for human obesity (Frank *et al*. [2010](#age12857-bib-0074){ref-type="ref"}; Jacob *et al*. [2018](#age12857-bib-0106){ref-type="ref"}). Likewise, naturally occurring equine asthma is recognized as a model for some forms of asthma in humans (Bullone & Lavoie [2017](#age12857-bib-0034){ref-type="ref"}; Bond *et al*. [2018](#age12857-bib-0025){ref-type="ref"}). As an athletic species, the horse is considered as an important large animal model for cardiovascular disease (Tsang *et al*. [2016](#age12857-bib-0271){ref-type="ref"}) and musculoskeletal disorders, including osteoarthritis (McCoy [2015](#age12857-bib-0161){ref-type="ref"}), as well as a model for articular cartilage repair and regeneration studies (Dias *et al*. [2018](#age12857-bib-0052){ref-type="ref"}). The horse has also been proposed as a potential model for immune response for infections, such as acute synovitis and septic arthritis (Ludwig *et al*. [2016](#age12857-bib-0150){ref-type="ref"}), and autoimmune disorders like recurrent uveitis (Witkowski *et al*. [2016](#age12857-bib-0295){ref-type="ref"}). Furthermore, studies of melanoma in gray horses are expected to help dissect the molecular mechanisms underlying melanoma as well as vitiligo in humans (Rosengren Pielberg *et al*. [2008](#age12857-bib-0227){ref-type="ref"}; van der Weyden *et al*. [2016](#age12857-bib-0293){ref-type="ref"}).

Functional annotation of the equine genome {#age12857-sec-0024}
==========================================

Despite the recent and rapid successes in identifying causative mutations for these mostly simple inherited traits, the genetic investigation of complex traits has not been as straightforward. Although there is strong evidence for the heritability of many complex diseases and traits (described above), despite a significant financial investment by the equine industry in phenotyping and genotyping large numbers of horses, functional genetic mutations have not been discovered for most complex traits examined (Table [4](#age12857-tbl-0004){ref-type="table"}).

Finding genetic associations of chromosomal segments to a specific phenotype without identifying functional or causative mutations within protein‐coding genes is not a problem unique to the horse. The idea that much of the non‐coding genome is 'junk DNA' (Ohno [1972](#age12857-bib-0191){ref-type="ref"}) and uninteresting to consider further has been reconsidered after overwhelming evidence from the human and murine Encyclopedia of DNA Elements (ENCODE) projects, demonstrating that these regions are functionally important (Consortium *et al*. [2007](#age12857-bib-0046){ref-type="ref"}; Yue *et al*. [2014](#age12857-bib-0300){ref-type="ref"}). As many as 93% of the associated and potentially causative variants from human GWAS publications are outside of annotated protein‐coding regions (Hindorff *et al*. [2009](#age12857-bib-0101){ref-type="ref"}). It is unlikely that these associations are aberrant, but rather they are identifying genomic regions involved in processes other than protein coding, such as regulation of gene expression (Maurano *et al*. [2012](#age12857-bib-0160){ref-type="ref"}). In addition to the recent discovery that the majority of the genome is transcribed (Consortium *et al*. [2007](#age12857-bib-0046){ref-type="ref"}), it has also been shown that 92--94% of human protein‐coding genes express multiple mRNA variants or isoforms (Wang *et al*. [2008](#age12857-bib-0287){ref-type="ref"}). Many of the variants responsible for mapped equine diseases and traits in Table [3](#age12857-tbl-0003){ref-type="table"}, in addition to others, may be regulatory, non‐coding mutations.

The need for defining the tissue‐specific gene expression and regulation (i.e. functional annotation) across domestic animal species was acknowledged by the establishment of the International FAANG project (Andersson *et al*. [2015](#age12857-bib-0005){ref-type="ref"}). The ultimate goal of this initiative is to provide high‐quality functional annotation of animal genomes in a coordinated effort that facilitates data sharing and analysis, while establishing standards for assay quality and continuity for metadata analysis. In an effort to establish a more direct connection between genome function and phenotype, the FAANG consortium has focused on initially assaying tissues from one to two individual animals representing a breed with minimal genetic diversity within a species (Andersson *et al*. [2015](#age12857-bib-0005){ref-type="ref"}). The resulting data from this annotation across species will provide power to associate phenotypes with functional data, making it possible to generate and test hypotheses regarding the functional mechanisms underlying associations (Tuggle *et al*. [2016](#age12857-bib-0272){ref-type="ref"}; Giuffra *et al*. [2019](#age12857-bib-0086){ref-type="ref"}).

As demonstrated by the human and murine ENCODE projects, five types of assays uncover the majority of variation in tissue‐specific gene expression and epigenetic modifications:

*Expression*---RNA‐seq identifies expression levels of primarily protein‐coding genes.*RNA expression*---small RNA‐seq identifies expression of miRNAs, non‐coding RNAs that function primarily in RNA silencing.*Histone modifications*---ChIP‐seq identifies genome‐wide patterns of histone modifications using antibodies against the modified histone proteins. These prioritized marks have been standardized across species and those focused upon for the FAANG initiative and the genomic features they identify include H3K4me1 (enhancers and distal regulatory elements), H3K4me3 (active promoters and enhancers), H3K27me3 (gene silencing) and H3K27ac (active regulatory elements; Lee *et al*. [2014](#age12857-bib-0131){ref-type="ref"}).*Chromatin accessibility*---the Assay for Transposase‐Accessible Chromatin using sequencing (ATAC‐seq) identifies regions of open chromatin.*DNA methylation*---reduced representation bisulfite sequencing identifies DNA methylation across the genome.

In line with the priorities of the FAANG initiative, in 2016, an equine biobank was created based on the sampling and preservation of 86 tissues, two cell lines and fluids from two Thoroughbred mares (Table [5](#age12857-tbl-0005){ref-type="table"}; Burns *et al*. [2018](#age12857-bib-0035){ref-type="ref"}). Tissues were flash frozen, preserved for histopathology, fixed for chromatin‐immunoprecipitation, and in 16 tissues, nuclei isolation was conducted. This biobank is available for all researchers to access for assays appropriate to the goals of the FAANG initiative. Notably, extensive ante‐ and post‐mortem evaluation by veterinarians was conducted on these two horses to provide the highest standard of a true 'reference' database for researchers to utilize. In addition, both mares represented in the biobank had normal karyotypes. Utilizing the strict standard of phenotyping allows for both association of phenotype with genomic data and standardization of future sampling efforts, enhancing the utility of the data generated (Burns *et al*. [2018](#age12857-bib-0035){ref-type="ref"}).

###### 

Biobank tissues collected from two Thoroughbred mares.

+------------------------------+---------------------------------+----------------------------+
| Musculoskeletal system:      | Nervous system:                 | Digestive system:          |
|                              |                                 |                            |
| *Cartilage* --- *Fetlock*    | *Cerebellum Vermis*             | *Cecum*                    |
|                              |                                 |                            |
| *Cartilage* --- *Stifle*     | *Cerebellum Lateral Hemisphere* | *Duodenum*                 |
|                              |                                 |                            |
| Coronary Band                | *Cornea*                        | Epiglottis                 |
|                              |                                 |                            |
| *Deep Digital Flexor*        | Corpus Callosum                 | Esophagus                  |
|                              |                                 |                            |
| *Gluteal Muscle*             | *C1 Spinal Cord*                | *Ileum*                    |
|                              |                                 |                            |
| **Lamina**                   | C6 Spinal Cord                  | *Jejunum*                  |
|                              |                                 |                            |
| Long Bone Marrow             | *Dorsal Root Ganglia*           | Left Dorsal Colon          |
|                              |                                 |                            |
| **Longissimus Dorsi**        | Dura Mater                      | Left Ventral Colon         |
|                              |                                 |                            |
| *Metacarpal Bone Diaphysis*  | *Frontal Cortex*                | Right Dorsal Colon         |
|                              |                                 |                            |
| *Rib Bone Marrow*            | *Hypothalamus*                  | Right Ventral Colon        |
|                              |                                 |                            |
| *Sacrocaudalis Muscle*       | L1 Spinal Cord                  | Small Colon                |
|                              |                                 |                            |
| *Sesamoid Bone*              | *L6 Spinal Cord*                | Stomach                    |
|                              |                                 |                            |
| *Superficial Digital Flexor* | *Occipital Cortex*              | Tongue                     |
|                              |                                 |                            |
| *Suspensory Ligament*        | **Parietal Cortex**             | Abdominal/thoracic organs: |
|                              |                                 |                            |
| Cardiovascular system:       | *Pituitary*                     | *Adrenal Cortex*           |
|                              |                                 |                            |
| Aortic Valve                 | Pons                            | Adrenal Medulla            |
|                              |                                 |                            |
| *Heart Left Atrium*          | *Retina*                        | *Kidney Cortex*            |
|                              |                                 |                            |
| **Heart Left Ventricle**     | Sciatic Nerve                   | *Kidney Medulla*           |
|                              |                                 |                            |
| *Heart Right Atrium*         | *Temporal Cortex*               | *Larynx*                   |
|                              |                                 |                            |
| *Heart Right Ventricle*      | Thalamus                        | **Liver**                  |
|                              |                                 |                            |
| **Left Lung**                | *T8 Spinal Cord*                | Lymph Node                 |
|                              |                                 |                            |
| *Mitral Valve*               | Cell types:                     | Pancreas                   |
|                              |                                 |                            |
| Pulmonic Valve               | *Fibroblasts (culture)*         | *Spleen*                   |
|                              |                                 |                            |
| Trachea                      | *Keratinocytes (culture)*       | Thyroid                    |
|                              |                                 |                            |
| Tricuspid Valve              | *PBMCs*                         | Integumentary system:      |
|                              |                                 |                            |
| Urogenital System:           | Body fluids:                    | *Dorsum Skin (over back)*  |
|                              |                                 |                            |
| Cervix                       | Plasma                          | Gluteal Adipose            |
|                              |                                 |                            |
| *Mammary Gland*              | Serum                           | **Loin Adipose**           |
|                              |                                 |                            |
| **Ovary**                    | Cerebrospinal fluid             | Neck Skin                  |
|                              |                                 |                            |
| Oviduct                      | Synovial fluid                  |                            |
|                              |                                 |                            |
| Urinary Bladder              |                                 |                            |
|                              |                                 |                            |
| *Uterus*                     |                                 |                            |
|                              |                                 |                            |
| Vagina                       |                                 |                            |
+------------------------------+---------------------------------+----------------------------+

Updated from Burns *et al*. ([2018](#age12857-bib-0035){ref-type="ref"}). Prioritized tissues for study are in bold. Additional tissues from which RNA‐seq data have been collected as funded by outside collaborators are shown in italics.
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Eight tissues were prioritized in the initial equine annotation efforts (Table [5](#age12857-tbl-0005){ref-type="table"}) owing to their cross‐species application (e.g. skeletal muscle, liver, lung and ovary) as well as importance to the horse (laminae). Additionally, as an international collaborative initiative, 24 individuals representing 16 research institutions in 10 countries voluntarily participated to support RNA‐seq of additional tissues by providing funding for transcriptome characterization of the tissue(s) most relevant to their own research; RNA‐seq datasets from these tissues are publicly available (EMBL: <http://www.ebi.ac.uk/embl/>). Seven laboratories also conducted additional assays, such as karyotype analyses, centromere mapping of fibroblast cells, reduced representation bisulfite sequencing of the eight priority tissues, fibroblast functional assays, functional assays on tissues of the suspensory apparatus and further phenotyping through the sequencing of microbiome samples.

ChIP assays for four histone modification marks were recently completed on the eight prioritized tissues. At this time, ChIP assays for the major insulator‐binding protein in vertebrates, CCCTC‐binding factor and ATAC‐seq experiments are underway. All datasets will then be fully integrated and correlated with gene expression data and made publicly available as an equine‐specific tissue atlas to the entire equine research community.

Future directions {#age12857-sec-0025}
-----------------

With the sheer volume of sequencing efforts currently underway in the horse, in addition to the FAANG efforts to define regulatory regions of the genome, the genetic contributions to complex traits can be discovered. Many of these more complex diseases (Table [4](#age12857-tbl-0004){ref-type="table"}) probably have strong environmental contributions to the overall phenotype. Therefore, educating veterinarians and horse owners on the proper use of these genetic 'risk factors' in breeding management will be essential to advance the health of horses.

Concluding remarks and future perspectives {#age12857-sec-0026}
==========================================

In this review, we demonstrate that the 10 years of post‐genome era in equine genomics have been unparalleled and decorated with outstanding achievements in almost all conceivable directions. These include improved characterization of the structure and function of the horse genome, delineating the genetic makeup of breeds and populations, deciphering the evolutionary ancestry of horses and continuing search for molecular causes of Mendelian and complex traits and diseases. The central pillar of support for this success is definitely the high‐quality horse reference genome combined with unprecedented advances in genomics technologies and global collaborations between researchers of diverse disciplines, clinicians, breeders and horse owners.

Whereas similar achievements characterize the post‐genome era of all main domestic species, it must be emphasized that the collection of genome‐level sequence data from hundreds of ancient horses from the past few thousand years is unparalleled and not available for any other domestic or non‐primate species. This unique resource allows researchers to track the evolutionary past of any genomic features, particularly the sequence variants that are associated with equine traits of importance, such as performance, coat color, disease and adaptations. This also demonstrates that the history of domestic animals cannot be fully understood without ancient genomic data.

The enhanced knowledge about the horse genome, biology and populations also highlights the areas that require critical improvement. Among these, high expectations are put on the equine FAANG initiative in order to identify important functional elements in the horse genome, particularly those underlying simple and complex traits. Also, the growing number of available WGSs of individual horses of diverse breeds and phenotypes allows for a comprehensive catalog of common and rare variants in the horse genome. This in turn is the foundation for equine precision medicine, which should identify novel genetic mutations in a small number of individuals and connect the variation with function.
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**Table S1** Genetic variants identified for traits influencing pigmentation.
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**Table S2** Genetics variants underlying disease and performance traits in the horse.
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